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1. Abstract 
 
Molecular interactions of collagen XVI in Crohn’s disease 
In Crohn’s disease (CD) the stress-shield of intestinal subepithelial myofibroblasts 
(ISEMF), provided by intact tissue is disturbed due to inflammation and cells start with 
remodelling activities. This is characterized by increased numbers of collagen-
producing ISEMF causing an uncontrolled, irreversible wound-healing response to the 
chronic inflammation of the gastrointestinal tract. Reconstitution of the original 
extracellular matrix (ECM) leads ISEMF to exit this cycle, however, in fibrosis ISEMF 
remain. It is known that ISEMF produce and deposit collagen types I, III, IV and V; but 
synthesis and the role of fibrillar peripheral molecules like collagen type XVI have not 
been addressed yet. Here, we have analyzed distribution of collagen XVI in the normal 
and inflamed bowel wall, its gene and protein expression by ISEMF of different 
inflammation stages, the cell-matrix interactions in different phases of the inflammatory 
process and the effect of collagen XVI on cell proliferation and migration. Collagen 
XVI is deposited in the submucosa of the intestinal wall and ISEMF reveal increasing 
gene and protein expression of collagen XVI with concurrent increasing inflammation. 
ISEMF display more mature focal adhesion contacts when seeded on collagen XVI 
resulting in an extensive cell spreading. This might involve recruitment of α1 integrin, 
since its cell surface expression on ISEMF is increased in late stages of inflammation. 
We assume that collagen XVI promotes persistence of ISEMF in the normal and even 
stronger in the inflamed bowel wall by stabilizing focal adhesion contacts via cell-
matrix interaction preferentially through recruitment of α1ß1 integrin into the focal 
contacts. 
Mechanistical studies of collagen XVI by a retroviral mediated knockdown model 
in murine fibroblasts 
Collagen XVI, a member of FACIT collagens (fibril associated collagens with 
interrupted triple helices) is described as macro-molecule of the ECM. Very little is 
known about its role in cell-matrix-interactions and in cell signalling. However it has 
been demonstrated that cells interact with collagen XVI via integrin α1β1 and α2β1. 
These interactions presumably determine organization of extracellular components and 
their communication with cells. We have established a retroviral mediated collagen XVI 
knockdown in NIH3T3 fibroblasts to investigate the role of collagen XVI in cell-matrix 
interactions. Specific shRNAs against collagen XVI were utilized in parallel to a viral 
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luciferase vector construct as control. After successful transduction, positive cell clones 
were further selected by antibiotic resistance. Knockdown efficiency was determined on 
mRNA and protein level and further downstream experiments were performed with 
respect to adhesion and proliferation. Differential protein expression in knockdown cells 
was compared to the control by 2D-gelelectrophoresis.  
The knockdown resulted in 80-90 % inhibition of collagen XVI gene and protein 
expression and mass spectrometry revealed several differentially expressed proteins. 
Collagen XVI inhibited cell lysates showed a lack of macrophage migration inhibitory 
factor (MIF) and prolylpeptidyl-cis-trans-isomerase A (PPIA). The gene expression of 
these proteins was slightly up-regulated, however, western blot analysis confirmed 2D-
gelelectrophoresis results. Proliferation of knockdown cells was generally reduced and 
was not influenced by the presence of collagen XVI as cell culture substrate. The 
cytokine MIF influences migration and proliferation of fibroblasts during wound 
healing. MIF induces synthesis of collagens in fibroblasts (collagen I, III, IV, V and VI) 
whereas PPIA contributes to correct protein folding in the cytoplasm of cells. Collagen 
XVI acts as adapter molecule in organizing suprastructures. Therefore, we assume that 
the lack of collagen XVI detains fibroblasts in arranging fibrillar stuctures which results 
in disturbed initial adhesion. The amelioration of cellular adhesion to the available 
matrix indicates a compensation in integrin expression pattern. Reduced proliferation 
together with decreased MIF expression hints at changes in the differentiation stage and 
has to be further elucidated.  
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2. Preface 
 
The most exciting phrase to hear in science, the one that heralds new discoveries, is not 
‘Eureka’ (I found it!) but ‘That’s funny…’ Isaac Asimov 
 
2.1. Molecular constituents of the ECM 
Multicellular organisms comprise of ingenious arrangements of cells and surrounding 
molecules. Structural integrity and functionality in tissues are determined by a highly 
organized architecture of extracellular matrix generated by residing cells and culminates 
in organ development. The extracellular matrix is not only giving shape and mechanical 
resilience in a tissue, it is also directly interacting with cells and this form of 
communication is influencing cell differentiation, proliferation, adhesion and migration. 
The function of extracellular matrix exceeds simple mechanical tasks and is involved in 
complex cell-matrix interactions.  
The extracellular matrix comprises of collagens, proteoglycans and further 
macromolecular components. These constituents and their composition vary according 
to tissue-specific or evolutionary requirements.  
 
2.1.1. Collagens – a family portrait 
Around 30 % of protein in all tissues are collagens, the most abundant proteins in 
mammals. Collagens are glycoproteins that are characterized by a triplehelical structure 
enabled by a specific repetitive amino acid sequence: (Gly-Xaa-Ybb)n. Glycine is 
located in the inner part of the clockwise turning helix and Xaa and Ybb are often 
allocated by proline that stabilizes the triple-helical structure if hydroxylized. There is a 
huge complexity and diversity of the 29 identified collagens that form various 
supramolecular structures. 
The biosynthesis of collagens is basically characterized for fibrillar collagens that 
underlie co- and posttranslational modifications. The intracellular modifications require 
at least 9 hydroxylases and glycosyltransferases (Lamande and Bateman, 1999) and 
comprise hydroxylation of some proline and lysine residues and the glycosylation of 
several hydroxylysine and asparagine residues. This is occurring sequentially in the 
rough endoplasmic reticulum whereas the Golgi apparatus is mediating the association 
of a stable triple helix from the C-terminus towards the N-terminus. The resulting 
soluble pro-collagen is secreted into the extracellular space and proteolytically cleaved. 
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The separation of N- and C-propeptides is leading to an insoluble collagen molecule 
that can spontaneously assemble to collagen fibrils (Birk and Silver, 1984; Jones et al. 
1998; Richard-Blum and Ruggiero, 2005). 
Collagens differ extremely in their complex structural and functional characteristics. 
Therefore, the term collagen underlies some simplifying criteria: The protein has to be 
found in the extracellular space and has to contribute to structural integrity of the ECM. 
It must contain at least one triple-helical domain and assemble in supramolecular 
structures, either alone or together with other matrix components (Jacenko et al. 1991). 
According to their amino acid sequence, their molecular composition, and their 
function, collagens are divided into several subfamilies (Table 2-1). Basically there are 
two major groups: fibrillar and non-fibrillar collagens. Fibrillar collagens comprise 
collagen type I, II, III, V, XI, XXIV, XXVII and are able to form stable fibrils. They 
represent around 90 % of all collagens found in mammals and share homologies in their 
molecular structure. A collagenous domain of around 1000 amino acids represents the 
middle part of an alpha chain, framed by a highly conserved non-collagenous C-
terminal and a variable N-terminal domain. Procollagens assemble as homo- or 
heterotrimers and after cleavage of N- and C-terminal propeptides the processed 
collagen-trimers form around 300 nm long triple helices: the collagen fibrils (Bornstein, 
1974; Prockop and Kivirikko, 1995). The aggregation is laterally staggered, therefore, 
in transmission electron microscopy with heavy metal contrast 63-67 nm periodically 
D-banded fibrils occur.  Dependent on the tissue and the localization in the tissue the 
fibrils vary in their size and their heterogenous composition.  
Non-fibrillar collagens are divided into several subgroups. Collagen IV and VII are 
basement membrane collagens that are grouped by their molecular structure but form 
different aggregates. Collagen VII builds anchoring fibrils, whereas collagen IV 
assembles in C-terminal aggregated net-like tetramers. Together with these collagens 
also the multiplexin-collagens type XV and XVIII occur in the basement membrane. 
Collagen VI, VIII and X are grouped in the family of short collagens that share the 
feature of just one collagenous domain framed by huge non-collagenous domains. The 
short collagens assemble in different tissues as hexagonal networks. Transmembrane 
collagens are represented by collagen type XIII, XVII, XXIII and XXV. They form 
homotrimers with an N-terminal intracellular domain, a hydrophobic transmembrane 
part and an extracellular C-terminus that varies in a different number of triple helical 
domains (Franzke et al., 2003).  
Preface   
 - 5 -
Collagen family Family member Integrin binding sites 
identified for: 
Fibril-forming collagens Collagen I, II, III, V, 
XI, XXIV, XXVII 
Collagen I,II,III, V 
monomers 
α2β1, α1β1, α10β1, 
α11β1 
Collagen XI monomers 
α2β1 
Collagen I fibrils α2β1, 
α11β1 
Denatured collagen I 
α5β1, αVβ1 
C-propeptide in 
collagen I and II  α2β1 
 
FACITs (fibril associated 
collagens with interrupted 
triple helices) 
Collagen IX, XII, XIV, 
XVI, XIX, XX, XXI, 
XXII 
Collagen IX 
α2β1, α1β1, α10β1, 
α11β1 
Collagen XVI 
α2β1, α1β1 
Hexagonal networks 
forming collagens 
Collagen VIII, X Collagen X 
α2β1 
Collagen VIII 
α2β1, α1β1 
Basement membrane 
collagen 
Collagen IV, VII Collagen IV 
α1β1, αVβ3, αVβ5,α3β1 
Beaded-filaments forming 
collagen 
Collagen IV Collagen IV α1β1, 
α10β1, α2β1, α11β1 
Anchoring fibrils forming 
collagen 
Collagen VII Collagen VII α2β1 
Transmembrane collagen Collagen XIII, XVII, 
XXIII, XXV 
Collagen XIII 
α1β1 
Collagen XVII  
α5β1, αVβ 
Multiplexins Collagen XV, XVIII Collagen XVIII  
α5β1, αVβ3, αVβ5 
 
Table 2-1: Collagen types and interacting integrins (Heino, 2007). 
 
2.1.2. The FACIT- collagen type XVI 
The largest group of collagens is the family of FACIT-collagens. The first discovered 
members collagen IX, XII, XIV were associated to fibrillar collagens, therefore, they 
were termed fibril associated collagens with interrupted triple helices (FACIT) that do 
not form fibrils on their own (Gordon et al., 1989; Richard-Blum et al., 2000). Collagen 
IX, for example, is covalently bound to the fibril surface and was proven to act as a 
linker protein between cartilage fibrils and other matrix components (Budde et al., 
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2005). The function of most FACITs could not be elucidated completely, however, it 
has been proposed that these collagens play a role in stablizing and/or in organizing 
fibrillar networks in the extracellular matrix. Although FACITs vary in their size and 
exhibit a huge structural diversity they all share common structural features. Two highly 
conserved cysteine residues are separated by four amino acids in the junction between 
the first collagenous (COL) and the first non-collagenous (NC) domain and two G-X-Y 
triplet imperfections in the first collagenous domain. The collagens IX, XII, XIV, XVI, 
XIX, XX, XXI and XXII were grouped according to these conserved features. FACIT-
collagens are further characterized by collagenous amino acid sequences that are 
interrupted and flanked by non-collagenous domains. The domains are sequentially 
numbered from the C-terminal part. Some non-collagenous domains display homologies 
to functional parts of other matrix proteins. All FACIT-collagens harbour a proline-
arginin-rich protein sequence (PARP) that shows similarities to thrombospondin 
(TSPN). Collagen type XII, XIV and XX also display in their N-terminus several von-
Willebrandt-Factor-A-domains (VA-domain) and some fibronectin-III-domains (F3) 
(Richard-Blum et al., 2000). 
In 1992 the cDNA sequence of collagen XVI has been discovered in a screening of 
cDNA banks for collagen-like sequences (Pan et al., 1992; Yamaguchi et al., 1992). The 
cDNA of 5.4 kb comprises a 4809 bp coding sequence, framed by non-translated parts, 
including a 425 bp 3’-non-coding sequence. Collagen XVI has been localized on 
chromosome 1, 1p34-35 (Pan et al., 1992). The coding sequence of collagen XVI 
comprises of 1604 amino acids including a 21 amino acid signal peptide, whereas the 
recombinant version of the protein has 1597 amino acids (Kassner et al., 2004). 
Collagen XVI appears as homotrimer of three identical alpha1-chains each consisting of 
10 collagenous and 11 non-collagenous domains. The 312 amino acid N-terminus 
harbours the PARP-motif, the TSPN-domain. The typical conserved imperfections in 
the intersection of COL1 and NC1, the Cys-Xaa-Ybb-Cys-motif is also found in 
collagen XVI and assigns this protein to the FACIT-family of collagens. Collagen XVI 
contains seven of these imperfections.  
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Figure 2-1: The domain structure of collagen XVI (Pan et al., 1992; Richard-Blum et 
al., 2000). 
COL: collagenous domains, NC: non-collagenous domains, TspN: Thrombospondin-
like domain. The N-terminus harbours the TSPN-domain. Each of the three identical 
alpha1-chains forming a homotrimer consists of 10 collagenous and 11 non-collagenous 
domains.  
 
Collagen XVI comprises three identical alpha1-chains each of around 200-220 kDa 
according to globular protein standards. The full length protein is proteolytically 
cleaved with respect to the expressing cell type, without any hint of splice variants. 
Polypeptide antibodies targeting the NC11-domain detect cleavage products of 40 kDa, 
65 kDa and 70-90 kDa in the cell culture supernatant of fibroblasts (Akagi et al., 1999; 
Tajima et al., 2000). Quantified with the same antibody, medium of fibroblasts and 
medium and cell lysate of dendrocytes showed peptides of 220 kDa, 180 kDa, 130 kDa 
and 62 kDa (Akagi et al., 2002). After immuno-precipitation cell lysates and cell culture 
supernatants of smooth muscle cells and dermal fibroblasts displayed protein fragments 
of 220 kDa, 180 kDa, 150 kDa, 130 kDa and 75 kDa (Grassel et al., 1996; Grassel et al 
1998). 
Recombinant collagen XVI was over-expressed in an episomal system in HEK 293 
EBNA cells and secreted into the cell culture medium. A C-terminal Strep-Tag allowed 
the purification of collagen XVI by affinity chromatography. The protein was 
characterized by N-glycosylated alpha1 chains assembled in trimers that were attached 
by disulfide bonds.   
The N-terminal sequencing of recombinant collagen XVI could identify several 
cleavage products (213 kDa, 182 kDa, 133 kDa, 78 kDa) with their specific cleavage 
sites (Kassner et al., 2004). The sequence of the full length protein with 213 kDa 
comprises the BM40 signal peptide followed by the collagen XVI sequence. The 182 
kDa fragment starts at amino acid 257 and lacks the NC11 domain cleaved within the 
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sequence KARRD between R(256) and D(257). This sequence contains a furin cleavage 
recognition site (Tillet et al., 1995). The 78 kDa fragment comprises COL1 and COL2 
with a cleavage site in the NC3 domain within the sequence AELG between E(941) and 
L(942). This amino acid sequence could be detected by aggrecanase-1 and -2, namely 
ADAM TS4 and ADAM TS5 (Tortorella et al., 2001). Collagen XVI appears in 
electron microscopy as flexible filamentous molecule with a clover-leaf shaped NC11 
domain. The full length protein is of an average size of 240 nm and is posttranslational 
hydroxylized. It shows a decreased thermo-stability compared to authentic collagen 
XVI. Binding studies displayed a high affinity to fibronectin, whereas fibrillin-1 / -2 
bind with a lower affinity to collagen XVI. None of these molecules shows any affinity 
to the recombinant NC11 domain (Kassner et al., 2004).  
 
2.2. Molecular assemblies involving collagen XVI 
Collagen XVI is expressed by keratinocytes (Grassel et al., 1999), fibroblasts and 
smooth muscle cells (Grassel et al., 1996), neuronal cells of the dorsal root ganglion 
(Hubert et al., 2007), chondrocytes (Kassner et al., 2003), and dendrodytes, a subgroup 
of dermal dendritic macrophages able to differentiate from blood monocytes after 
interleukin-4 stimulation (Akagi et al., 2002). 
In the embryonic development of the mouse collagen XVI showed a tissue distribution 
comparable to fibrillar collagens, however, temporarily delayed. Collagen XVI was 
widely expressed except for skeletal muscles, lung, and brain. m-RNA expression 
started at day 11 in the heart followed by spinal nerve fibres, fibrous connective tissue 
of the liver, intestinal tissue and differentiated chondrocytes. It was also expressed in 
ovary, testis, eye, skin and smooth muscle cells which altogether indicates a 
mesenchymal origin and displays collagen XVI mainly in the neighbourhood of 
basement membranes (Lai and Chu, 1996). 
In the human skin collagen XVI is expressed with respect to the cellular origin within 
the several layers of the skin. Collagen XVI is located close to basement membranes 
within the dermo-epidermal junction (DEJ) of the upper papillary dermis and around 
blood vessels. In the DEJ collagen XVI is co-localized with fibrillin-1 containing 
microfibrils however not in deeper dermis layers (Grassel et al., 1999). Fibroblasts that 
are non-adherent or confluent express less collagen XVI than cells of another phase of 
the cell cycle which is in contrast to the expression of collagen I sharing the same 
conditions (Tajima et al., 2000). 
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Skin fibroblasts and smooth muscle cells reacted to TGF-ß1 stimulation with an 
increase of collagen XVI expression. The stimulation also resulted in an augmented 
deposition of collagen XVI in the ECM, whereas FGF-2 repressed collagen XVI gene 
expression and biosynthesis (Grassel et al., 1998).  
In human adult costal cartilage collagen XVI was identified as part of the ECM. 
Collagen XVI is localized in the peri-cellular area within the territorial matrix of 
chondrocytes, however, it is not co-localized with fibrillin-1 in cartilage tissue. 
Moreover, collagen XVI is associated with thin D-banded, collagen-containing cartilage 
fibrils (Kassner et al., 2003). 
 
2.3. Cell-matrix adhesion via integrins 
Integrins are structurally and functionally related heterodimeric cell surface receptors 
which mediate the adhesion of cells to the ECM. They are involved in regulatory 
processes, the embryonic development, angiogenesis and tumorigenesis. So far, 18 α-
subunits and 8 β-subunits are known that form 25 integrin heterodimers (Fig. 2-2). 
Integrins link the actin cytoskeleton to the ECM and therefore convey information about 
localization and surrounding to the cell (Gullberg and Lundgren-Akerlund, 2002; 
Pfarrer et al., 2003). Integrins are grouped in various systems, according to a conserved 
structure, composition of their subunits or their ligand specifity. Via integrins the 
components of the ECM not only induce cellular reactions like cell adhesion, spreading, 
migration, and gene activation in an outside-in manner, moreover, ECM can also be 
remodelled by cells in an inside-out fashion (Akiyama et al., 1989; Aplin et al., 1998). 
Weak binding conformation of integrins is altered by internal signals into an active 
adhesive conformation and results in an interaction with the extracellular matrix. A loss 
of adhesion activates several caspases which in turn induce anoikis, a form of 
programmed cell death (Pankov et al., 2003; Stupack et al., 2001).  
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Figure 2-2:  The integrin family.  
18 α-subunits are able to interact with 8 β-subunits to form an active integrin complex. 
The α-subunits containing an I domain able to bind collagens are marked in dark grey 
(Gullberg and Lundgren-Akerlund, 2002). 
 
2.3.1. Structure of integrins 
Both subunits comprise a huge extracellular, a short transmembrane domain and a 
cytoplasmic part. α- and β-subunits are non-covalently bound and display a low ligand 
affinity. Therefore, cells quickly adhere via integrins however they can also easily loose 
this connection serving as basis for cell motility and invasion (Brakebusch and Fassler, 
2003).  
The α-subunit comprises a large extracellular domain composed of a globular head on a 
stalk bearing a sevenfold β-propeller (Fig. 2-3). The I domain is the obligate ligand 
binding site. However, not all α-chains contain interaction sites (Hynes, 2002; Springer, 
1997). α-subunits without the I domain obtain their ligand specifity by a β-subunit 
bearing a highly conserved I domain, that is able to bind cations like Mn2+ or Mg2+ via a 
MIDAS (metal ion dependent adhesion site) motif. The binding of metal ions leads to a 
conformational change in the I domain that enables ligand binding (Humphries et al., 
2004). 
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The cytoplasmic domain of both chains connects the extracellular matrix with the actin 
cytoskeleton and triggers intracellular downstream processes by recruiting structural 
and interconnecting proteins. 
 
Figure 2-3: α- and β-subunits of 
integrins. 
The α- and β-subunits comprise a 
large extracellular domain, a 
transmembrane domain and short 
cytoplasmic tail. The β-propeller, 
which is able to bind bivalent 
cations, is located at the N-terminus 
of the α-chain. The β-subunit 
contains a N-terminal located I 
domain, that binds metal ions 
(Gullberg and Lundgren-Akerlund, 
2002). 
 
 
2.3.2. Collagen-binding integrins 
So far four collagen binding integrins are known, namely α1β1, α2β1, α10β1, α11β1 
(Camper et al., 1998; Gullberg and Lundgren-Akerlund, 2002; Velling et al., 1999). 
Studies on collagen-binding integrins in vitro show their activity and influence in cell 
adhesion, cell migration, control of collagen synthesis, matrix metalloproteinase (MMP) 
synthesis, remodelling of collagen matrices, cell proliferation, cell differentiation and 
angiogenesis (Bouvard et al., 2001). Important functions could be indentified in vivo: 
reorganization of collagen matrices within developing tendons, ligaments, periosteum, 
capsules of organs and in healing wounds (Stopak and Harris, 1982).  
 
2.3.3. Collagen XVI – a binding partner of α1β1 integrin and α2β1 integrin  
During embryonic development α1β1 integrin and α2β1 integrin are both widely 
expressed (Gardner et al., 1996; Wu and Santoro, 1994). In vivo α1β1 integrin 
expression is restricted to few cell types including capillary endothelial cells, fibroblasts 
and smooth muscle cells (Voigt et al., 1995). Integrin α2β1 is predominantly found in 
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highly differentiated cells such as placenta cells and chondrocytes. 
Immunohistochemical studies reveal its expression in fibroblasts, endothelial cells, on 
Schwann cells of ganglia and non neuroglia and epithelial cells from multiple sites (Wu 
and Santoro, 1994). A large variety of collagens from different families are able to act 
as ligands for integrins α1β1 and α2β1, including fibril forming collagens, FACIT 
collagens or basement membrane collagens (Table 2-1).  
Both integrins α1β1 and α2β1 mediate cell adhesion, cell migration and contract three-
dimensional collagen lattices. This contractile ability in vitro reflects their potential to 
modulate collagen-rich matrices. Analysis of the collagen-binding integrins on liver 
stellate cells reveals integrin α1β1 as the major integrin on myofibroblasts in vivo 
mediating collagen contraction while integrin α2β1 is induced upon in vitro culture. The 
ability of α1β1 integrin to mediate collagen gel contraction by stellate cells may take 
part in collagen turnover and collagen reorganization in liver fibrosis (Racine-Samson et 
al., 1997). Mice deficient of the α1β1 integrin are viable, however, they display a 
proliferation defect and a disturbed regulation of collagen synthesis in skin fibroblasts 
(Gardner et al., 1996; Gardner et al., 1999; Pozzi et al., 1998). Antibody studies and the 
use of integrin α1-chain-deficient mice have shown that integrin α1β1 plays an 
important role in inflammatory reactions and is a target in anti-fibrotic and anti-
inflammatory treatments (Gullberg and Lundgren-Akerlund, 2002). Integrins α1β1 and 
α2β1 are mainly involved in tissue injury and tissue inflammatory situations (Gullberg 
and Lundgren-Akerlund, 2002). 
The binding site of α1β1 integrin was localized to the C-terminal tryptic collagen XVI 
fragment comprising the collagenous domains COL1-3. α1β1 integrin requires the 
homotrimeric sequences GFOGER and/or GLOGER, however, does not tolerate the 
substitution of the arginine residues for a lysine residue (Xu et al., 2000).  Collagen XVI 
contains related amino acid sequences GLQGER (1065-1070) and GIKGER (1101-
1106) within the N-terminal part of the COL2 domain (Eble et al., 2006; Pan et al., 
1992). α1β1 integrin binds most likely to either one or both of the collagenous integrin 
recognition sites in the COL2 domain. The binding of α2β1 integrin to collagen XVI is 
much weaker compared to α1β1, however, it binds to the same region without this 
binding site being mapped in detail. The best decribed high affinity ligand of α1β1 
integrin is the heterotrimeric collagen IV, however collagen XVI binds with similar 
strength (Eble et al., 1993; Kern et al., 1993). The COL2 domain of collagen XVI 
harbours another integrin adhesion sequence, RGD. However, this binding site is not 
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accessible to RGD-dependent integrins within the triple-helical conformation (Eble et 
al., 2006). Additionally, the collagen-binding integrins α1β1 and α2β1 are independent 
of this RGD sequence (Eble et al., 1993; Eble et al., 2001). It has been proven that other 
putative binding sites like GGKGER (337-342) and GKAGER (672-677) located in the 
COL10 and COL6 domains of collagen XVI are no functional recognition sites for α1β1 
integrin. For both integrins, it has been demonstrated that they interact with their A 
domain of the α-subunit with collagen XVI (Eble et al., 2006). This suggests similar 
binding mechanisms as to other collagens (Emsley et al., 2000).  
 
2.4. Pathological disorders involving collagen XVI  
2.4.1. Collagen XVI in tumorigenesis 
The fibril forming collagens I, III, V and VI are usually not present in the brain 
parenchyma, but they are components of mesenchymal structures. In gliomas only few 
tumor cell types deposit collagens in the peritumoral zone. Collagen IV, a major 
component of basement membranes is deposited by endothelial cells and choroid plexus 
epithelial cells in healthy brain. In glioblastomas collagen IV is present in virtually all 
tumor vessels as well as in some giant glioma cells and in tumor cells around vascular 
proliferations. Some types of gliomas develop a collagen network around individual 
tumor cells. The expression pattern of collagens changes during the growth of gliomas 
in cell culture. A phenomenon known as mesenchymal shift manifests in deposition of 
collagens I, III, IV and VI by glioma cell lines (Paulus et al., 1994). Invasion of glioma 
cells into brain tissue is facilitated by remodelling of tumor associated ECM (Claes et 
al., 2007). By using differential gene expression microarray analysis to compare glioma 
cells with increased versus decreased migratory phenotype, an upregulation of collagen 
XVI gene expression in a subpopulation of cells showed increased migration 
(Tatenhorst et al., 2004). Collagen XVI has been the first member of the FACIT-
collagens that was designated to tumorigenesis of glioblastomas. It could be detected in 
tumor vessels and tumor cells. Glioma tissue and a subset of glioma cell lines showed 
an upregulated expression and secretion of collagen XVI. Glioma cell lines adhered 
strongly to recombinant collagen XVI while this adhesion was dramatically reduced 
after blocking the endogenous collagen XVI expression. However, recombinant 
collagen XVI did not have any effect on migration properties of these cell lines (Senner 
et al., 2008). Low collagen XVI expression in the central nervous system of adult mice 
corroborates the absence of collagen XVI expression in normal human brain (Lai and 
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Chu, 1996). Neuronal cell movement is related to collagen XVI expression by neurite 
growth cones following axotomy (Hubert et al., 2007). 
Collagen XVI expression in glioma cells is due to the mesenchymal drift of tumor cells 
during cell culture (Paulus et al., 1994), since tumor cells express collagen XVI in situ. 
Transforming growth factor-ß 2 (TGF-ß2) is upregulated in gliomas and induces 
collagen XVI expression in fibroblasts (Arslan et al., 2007; Grassel et al., 1998). 
Members of the FACIT collagens interconnect collagens and other components of the 
extracellular matrix and therefore collagen XVI may support the migration of glioma 
cells. Although, no migration promoting effect of recombinant collagen XVI in 
monolayer migration assays could be observed collagen XVI may act as migration 
promoting substance in combination with other factors. Collagen XVI supports several 
glioma cell lines in their adhesion (Senner et al., 2008). The integrin α1β1 is expressed 
on glioma cell surfaces and has been demonstrated to interact with high affinity with 
collagen XVI (Eble et al., 2006). This integrin is involved in cell adhesion and 
migration and controls tumor-ECM-interaction (Paulus et al., 1993). Knockdown of 
endogenous collagen XVI in the glioma cell line U87MG reduces this adhesion 
capacity. Glioma cells modulate their environment by modulation of ECM components 
resulting in altered adhesion and migration (Zamecnik, 2005). Collagen XVI fragments 
have been detected in glioblastoma tissue and glioma cells resembling the 180 kDa form 
lacking the N-terminal NC11 domain and the 130 kDa form which misses C-terminal 
regions (Kassner et al., 2004). Proteolytic fragments from other collagens (type IV, type 
XVIII) influence glioma cell growth and migration (Bix and Iozzo, 2005), therefore, 
also collagen XVI could act mitogenically rather by its fragments than by the full length 
protein. Gliomas secrete a large variety of matrix metalloproteinases (MMP-2, MMP-9) 
that could have generated the different collagen XVI fragments (Annabi et al., 2009; 
Nakada et al., 2003). It is speculated that the glioma itself regulates cellular functions by 
proteolytically cleaved collagen XVI fragments (Senner et al., 2008). 
 
2.4.2. Inflammatory bowel disease – Crohn’s disease 
Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the 
gastrointestinal tract. Crohn’s disease (CD) and ulcerative colitis (UC) are distinguished 
as clinical subtypes. In 1932, Crohn, Ginzburg and Oppenheimer described in their 
paper ‘a disease of the terminal ileum, affecting mainly young adults and characterised 
by a subacute or chronic necrotizing and circatrizing inflammation. The ulceration of 
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the mucosa is accompanied by a disproportionate connective tissue reaction which 
frequently leads to stenosis of the lumen of the intestine associated with the formation 
of multiple fistulas.’ During the following years the term Crohn’s disease had been 
introduced. CD can affect any part of the intestinal tract and leads to discontinuous 
transmural lesions of the bowel wall by an inflammatory process with mucosal damage, 
the presence of non caseating granulomas and fissures with formation of fistulas. UC 
inflammation is limited to the colon and rectum with superficial but continuous lesions 
and affects only the mucosa and submucosa except for most severe cases. In contrast to 
CD, UC extends continuously and proximally from the rectum. Annually 6 to 10 
incidences of CD per 100,000 occur in Western Europe and Northern America 
(Shivananda et al., 1996). 
 
2.4.2.1. The bowel wall – an introduction 
The intestinal wall comprises the mucosa (epithelial cells, lamina propria, lamina 
muscularis mucosae), submucosa, muscularis propria and serosa (Fig. 2-4). The inner 
lumen of the bowel wall is separated by the epithelial cell layer immobilized on the 
basal lamina. The main part of the mucosa consists of the lamina propria containing 
lymphocytes, macrophages, fibroblasts and capillaries within the extracellular matrix. 
The lamina propria is followed by the lamina muscularis mucosae and the submucosa. 
Lamina muscularis mucosae comprises about five cell layers of smooth muscle cells 
and is essential in the intestinal motility, whereas the submucosa is characterized as a 
loose meshwork of thin collagen fibrils connecting mucosa and muscularis propria and 
guiding blood and lymphatic vessels. Densely packed smooth muscle cells form the 
muscularis propria which is surrounded by collagen fibrils. These fibrils are 
interconnected with intramuscular septae. The longitudinal muscle layer is defined by 
connective tissue, the serosa, which separates the bowel from the peritoneum by an 
epithelial cell layer. 
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Figure 2-4: Composition of the normal bowel wall 
The intestinal wall comprises the mucosa (epithelial cells, lamina propria, lamina 
muscularis mucosae), submucosa, muscularis propria, and serosa. 
 
2.4.2.2. Pathophysiology and molecular mechanisms of CD 
The molecular basis of the pathogenesis of IBD is not yet clear, however, persistent 
bacterial infection, a defective mucosal barrier and an imbalance in the regulation of the 
intestinal immune response may contribute to the clinical manifestation of IBD 
(Podolsky, 2002). Chronic inflammation of the gastrointestinal tract is the main 
manifestation in CD and often accompanied by other systemic abnormalities. Terminal 
ileum and proximal colon are mainly affected by CD accompanied by an up-regulation 
of T-helper cells type 1 and pro-inflammatory cytokines like interferon-γ and 
interleukin-2. Monocytes and macrophages are stimulated to produce higher levels of 
TNF-α, interleukin-1 and interleukin-6. Individuals with a genetic susceptibility react to 
the bacterial flora in the intestinal tract with an abnormal inflammatory immune 
response (Shanahan, 2002). Established inflammatory lesions are regarded as the 
precondition for the onset of intestinal fibrotic processes. The excessive tissue repair is 
caused by a pathologically increased healing response to inflammation-induced 
disintegration of mucosal tissue. In contrast to normal wound healing chronic 
inflammation persists and occurs simultaneously with inflammation, tissue remodelling 
and repair processes (Wynn, 2007). Moreover, in fibrotic and wound granulation tissue 
extensive cell-matrix contacts occur (Singer et al., 1984). 
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2.4.2.3. Extracellular matrix composition in the colon 
In the gut predominant connective tissue proteins are the ubiquitous interstitial 
collagens type I, II, III, type IV in basement membranes and type V as pericellular 
collagen. The luminal surface of the mucosa is lined by epithelial cells. This cell layer 
covers a continuous basement membrane consisting of type IV collagen, heparin 
sulphate proteoglycan and laminin (Stanley et al., 1982). The underlying lamina propria 
supports the epithelium and represents a loose network of connective tissue comprising 
collagen types I, III, IV and V. The lamina propria facilitates absorption and secretion 
through capillaries and lymphatics. A compilation of mesenchymal cells including 
smooth muscle cells, subepithelial myofibroblasts and fibroblasts contribute to the 
extracellular matrix deposition.  
A thin layer of smooth muscle cells separates the mucosa from the submucosa and 
facilitates motility of the villi. The submucosa, a network of collagen fibrils connects 
the mucosa to the muscularis propria. The specific composition of collagen fibrils 
allows the mucosa to move over the muscularis propria (Graham et al., 1988; Komuro 
and Hashimoto, 1990). Densely packed smooth muscle cells, embedded in collagen 
fibrils represent the muscularis propria. In the human intestinal muscle predominantly 
collagen types I and III are present. 
 
2.4.2.4. Intestinal wound healing and fibrosis 
The architecture of the gastrointestinal tract is specified by a hollow, mucosa-lined 
muscular tube. Its functionality comprises an aboral movement of chyme, the absorption 
of water, electrolytes and nutrients and defense against harmful agents. The gut bears a 
huge capacity of healing itself after injury. Ineffective healing would result in necrotic 
tissue, perforation and the spillage of luminal contents into the peritoneum which may 
be lethal. Therefore, the healing function preponderates the organ function. Stricture 
formation is the natural response to chronic inflammation in CD, however, it may 
reduce its functionality (Graham et al., 1988). 
 
2.4.2.5. The role of intestinal myofibroblasts 
Mesenchymal cells like fibroblasts, myofibroblasts and smooth-muscle cells are the 
main producers of extracellular matrix components and play an important role in tissue 
growth and development in different tissues (Powell et al., 1999 ; Simon-Assmann et 
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al., 1995). Myofibroblasts are considered as central players in tissue repair contributing 
to fibrosis and stenosis by reconstituting collagen-rich ECM and promoting wound 
closure by contraction (Tomasek et al., 2002). Normal wound healing would terminate 
contractile and synthesizing activity of myofibroblasts by reduction of cell number 
through apoptosis (Desmouliere and Gabbiani, 1995). Chronic pathological tissue 
contractures, however, are characterized by continuity of exessive contractile and 
synthesizing activity over several years (Desmouliere et al., 2005 ; Gabbiani, 2003). It is 
an important prerequisite to understand how and why cells gradually loose their 
integrity in different phases of pathophysiological processes to improve diagnosis and 
therapy. The aim is to limit the progression of fibrosis as soon as possible without 
affecting the physiological repair process. A potential strategy to interrupt the impaired 
regeneration is to induce the disappearance of myofibroblasts from fibrotic tissue. 
Therefore, a modification of the regenerative potential involving matrix adhesion of 
myofibroblasts would be most effective (Desmouliere et al., 2005). 
 
2.4.2.6. Cell-matrix interaction in Crohn’s disease 
The delicate homoestasis between cells and surrounding ECM is already disturbed at 
the onset of CD and the levels of several fibrillar and non-fibrillar collagens (type I, III, 
IV, V, VI) are upregulated (Graham et al., 1988 ; Matthes et al., 1992 ; Pucilowska et 
al., 2000 ; Stallmach et al., 1992). Transmembrane receptors of the integrin family 
physically connect the ECM to the cellular cytoskeleton relaying to multiple signaling 
pathways. Thus ECM components and intracellular stress fibers are linked by actin 
coupled cell-matrix adhesions. This association with intracytoplasmic actin filaments 
enables force transmission from the myofibroblast to the substrate while intercellular 
connections synchronize myofibroblast contraction. Actin-integrin adhesion complexes 
involve several signaling pathways which in turn modulate complex formation (Geiger 
and Bershadsky, 2001). Initial ligation is followed by integrin attachment to the actin 
cytoskeleton (Jiang et al., 2003) and tractional forces are transmitted via adhesive 
structures called focal adhesions (FA) or focal contacts (FC) (Harris et al., 1980 ; 
Pelham, Jr and Wang, 1999). Usually, apoptotic processes occur after reconstitution of 
physiologically healing wounds and the myofibroblasts disappear (Desmouliere et al., 
2005), however, in fibrocontractive and –proliferative diseases the contractile activity of 
cells persists and leads to a continous remodelling and retraction of the ECM. 
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2.4.2.7. Treatment of Crohn’s disease 
Treatment of the disease either by drugs or surgical removal of inflamed intestinal parts 
do not result in complete cure of CD. However, there are several treatments available to 
allay the symptoms. Aminosalicylates, glucocorticoids, antibiotics, 
immunosuppressives and monoclonal antibodies are applied in different stages and 
localization of the disease according to table 2-2. 
 
Disease activity Symptoms Medication Alternatives 
Low Inflammation of 
the terminal ileum 
and/or colon 
Glucocorticoids  No antibiotics 
Moderate Inflammation of 
the terminal ileum 
and/or colon 
Glucocorticoids, 
additional antibiotics 
 
Acute Inflammation of 
the ileum and/or 
colon 
Systemic 
glucocorticoids, if 
recidivism also 
immunosuppressives 
If therapy is not 
successful: use of 
monoclonal 
antibodies 
Highly acute Large 
inflammation of 
the bowel 
Systemic 
glucocorticoids, 
aminosalicylates,  
If therapy is not 
successful: use of 
monoclonal 
antibodies 
 
Table 2-2: Indications for the medication of Crohn’s disease according to the guidelines 
of the European Crohn’s and Colitis Organization (ECCO). 
 
2.5. Gene-function analysis – RNA interference as a method of choice 
RNA interference (RNAi) is a potent tool to study the effects of the loss of a single 
protein. It is a valuable alternative to knock-down models in mice or zebrafish. Double-
stranded RNAs (dsRNA) are cleaved in 21-25 nucleotide (nt) short small interfering 
RNAs (siRNA) (Elbashir et al., 2001). These in turn initiate sequence-specific 
degradation of mRNA by simulation of endogenous microRNA (miRNA). Endogenous 
and exogenous interfering RNA duplexes are incorporated with a RNA-induced 
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silencing complex (RISC) which attaches to complementary mRNA resulting in gene 
silencing (McManus and Sharp, 2002).  
 
2.5.1. Gene suppression by short interfering RNA 
The central molecule in RNAi is dsRNA which is initially cleaved into short RNA 
fragments of around 23 bp by the Dicer molecule (Bernstein et al., 2001). Dicer starts at 
one end of the dsRNA and ATP-dependently cleaves fragments of 21-23 bp from the 
dsRNA. The siRNA is incorporated into a protein complex named RISC (RNA-induced 
silencing complex) (Hammond et al., 2000). RISC is activated by the ATP-dependent 
unwinding of the siRNA duplex. The active RISC recognizes a homologous target 
mRNA by base pairing and subsequently cleaves the mRNA at approximately 12 nt 
from the 3’-end of the siRNA. The siRNA strand is removed and most likely degraded, 
(Sijen et al., 2001; Smardon et al., 2000) and the resulting dsRNA again enters the 
RNAi circuit. On the other hand the nicked mRNA is further degraded and the RISC 
complex may be recycled to perform additional mRNA degradation.  
Establishing RNAi in mammalian cells is complicated by non-specific gene silencing 
and by profound physiological responses to dsRNA often leading to cell death. Here, 
the length of siRNA is essential. One single molecule of dsRNA longer than 30 
nucleotides is sufficient to trigger the interferon response. This anti-viral response 
results in global inhibition of translation (Manche et al., 1992) and mRNA is 
unspecifically degraded (Minks et al., 1979), finally leading to apoptosis (Clemens and 
Elia, 1997; Gil and Esteban, 2000; Sekellick and Marcus, 1985).  
 
2.5.2. shRNA-mediated silencing of mammalian gene expression 
The simplest secondary RNA structure is the hairpin structure. It is formed by a single-
stranded RNA folding back onto itself, resulting in a double-stranded RNA stem joined 
at one end by a single-stranded loop. The role of the hairpin RNAs is defined by tertiary 
interactions in RNA enzymes, protection of mRNAs from degradation and recognition 
by RNA-binding proteins. The sequence of the loop is almost unimportant as long as 
one stem strand is complementary to the targeted sense mRNA sequence 
(Brummelkamp et al., 2002; Paddison et al., 2002). Chemically synthesized DNA 
oligonucleotides that encode the chosen sequence are annealed to a double-stranded 
fragment. This fragment is subsequently cloned into a hairpin expression vector 
downstream from an eukaryotic promoter. DNA sequencing has to be performed since 
Preface   
 - 21 -
oligonucleotides that encode hairpins are relatively long (60-90 nucleotides) and 
possess a high degree of secondary structure. The introduction of shRNA constructs to 
cells can be accomplished by using any gene transfer technique, however, systems 
based on retroviral, lentiviral or adenoviral expression guarantee a well-characterized 
stable expression of shRNAs in target cells (Castanotto et al., 2002). For the gene 
silencing of collagen XVI we use a retroviral mediated mechanism. The retroviral 
expression vector is inserted into a packaging cell line. This cell type already contains 
genes for virus particle formation and replication, stably integrated into the genome. 
The retroviral expression vector provides the packaging signal ψ+, transcription and 
processing elements, and the target gene which are resulting in production of a 
replication-incompetent virus. A viral env gene encodes the envelope protein, which 
determines the range of infectivity (tropism) of the packed virus. The utilized ecotropic 
virus can only recognize a receptor expressed on mouse and rat cells. An antibiotic 
selection can be used to select cells that stably express the integrated vector. The virus 
produced by transfections can infect target cells and transmit genes of interest, however, 
it cannot replicate within the target cell. The whole mechanism is depicted in Fig. 2-5. 
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Figure 2-5: Mechanism of retroviral mediated gene silencing. The retroviral expression 
vector contains a puromycin resistance gene for the selection of stable transfectants and 
is transfected (1) into the cell and stably integrated into the genome of the packaging 
cell line (2). The packaging signal ψ+, transcription and processing elements, the target 
gene and viral proteins are stably expressed by the packaging cell line (3). The viral 
proteins recognize the packaging signal (4) and the virus is packed and transported 
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outside the cell (5). The target cell can be infected by uptake of the retrovirus (6). The 
viral RNA is transcribed into DNA (7) and stably integrated into the genome of the 
target cell (8). dsRNA is expressed (9) and processed by Dicer into siRNAs (10). The 
RISC complex is formed with siRNAs (11), the dsRNA is unwound (12) and results in 
an active RISC complex. The complex is recruited to the target mRNA (13) and finally 
leads to a specific mRNA cleavage (14).  
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3. Aim of the thesis 
 
The highest reward for man's toil is not what he gets for it, but what he becomes by it. – 
John Ruskin 
 
Background 
The gene and protein sequence of collagen XVI was described in 1992 (Pan et al., 
1992). Since then, it has been structurally and ultra-structurally characterized including 
post-translational modifications, possible cleavage- and integrin binding sites. Collagen 
XVI has been investigated in skin, cartilage and neural tissue. In the human skin it is 
part of the dermo-epidermal junction (DEJ) associated to the microfibrillar apparatus 
which is formed by fibrillin-1 containing microfibrils (Grassel et al., 1999). It has also 
been detected close to the basal membrane and in smooth muscle cells derived from 
blood vessels. In cartilage it is present in the territorial and pericellular zone of 
chondrocytes, where it is associated to the surface of D-periodically banded cartilage 
fibrils (Kassner et al., 2003). However, in cartilage it does not interact with fibrillin-1 as 
in skin. The suprastructurally different appearance of collagen XVI also indicates a 
tissue-specific functional diversity. For skin an interaction and connection of the 
microfibrillar apparatus with structures of the basal membrane via collagen XVI is 
proposed, whereas in cartilage collagen XVI seems to modify the fibrillar surface and to 
modulate interfibrillar interactions. 
The role of collagen XVI in neural tissue has also been the focus of several 
investigations. Collagen XVI is highly expressed in the peripheral nervous system 
during embryonal development and is re-expressed after axotomy. This specific 
expression pattern indicates that collagen XVI is involved in regeneration processes 
(Hubert et al., 2007). During progression of tumorigenesis of glioblastoma and 
astrocytoma collagen XVI was highly up-regulated. This suggests a role of collagen 
XVI in the course of the integration of tumors into the surrounding tissue (Senner et al., 
2008) where collagen XVI might support tumor integration into the healthy tissue.  
Collagen XVI and Crohn’s disease 
Expression pattern of collagen XVI in healthy and diseased tissue  
Crohn’s disease is a heterogenous entity which comprises several disease presentations: 
fibrotic strictures, penetration and chronic inflammation. As collagen XVI is up-
regulated in fibrotic diseases of the skin, we propose a role for this collagen in intestinal 
fibrotic diseases like Crohn’s disease. Collagen XVI is present in the intestinal system 
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and its molecular distribution and deposition pattern in the human physiological and 
pathological situation is one important investigation target. Here, immunofluorescence 
staining of collagen XVI in healthy and diseased tissue from CD patients is applied.  
The influence of the inflammatory progression of Crohn’s disease on collagen XVI 
expression and deposition 
CD patients progress through different stages of inflammation during the course of 
disease. Several collagens (collagen type I, III, IV, VI) have been reported to be up-
regulated in CD, however, irrespective to the grade of inflammation. We propose a role 
for collagen XVI in cell-cell and cell-matrix interactions dependent on inflammatory 
progression. Subepithelial myofibroblasts are central players in extracellular matrix 
deposition in the healthy intestines and in intestinal fibrotic diseases. The gene and 
protein expression of collagen XVI in these cells was investigated in 
immunofluorescence staining, immunoblotting and quantitative PCR. 
Characterization of intestinal subepithelial myofibroblasts and their interaction with 
collagen XVI  
Intestinal subepithelial myofibroblasts are important in the extracellular homeostasis, 
however, still not well described. Another aim of this work is to characterize these cells 
in their adhesion, proliferation, and migration properties with respect to their interaction 
with collagen XVI. Underlying mechanisms of cell-matrix interactions and integrin 
mediated processes involving collagen XVI are another investigation target. Spreading 
and attachment of the cells on several substrates (poly-L-lysine, 5 µg/ml; collagen I, 
10 µg/ml, collagen XVI, 10 and 30 µg/ml) is determined employing morphometric 
analysis of focal adhesion contacts and integrin expression pattern is investigated by 
flow cytometry and immunofluorescence. The same substrates are applied to analyze 
their influence on proliferation and migration capacity.  
Functional analysis of collagen XVI based on a gene silencing model 
Establishment of a stable knockdown of collagen XVI 
The reason of structural diversity of collagen XVI is still unclear. An approved method 
to determine the function of a protein is to deplete it as much as possible. In absence of 
a valid knock-out mouse model and in order to have a reproducible in vitro tool, RNA 
interference is the matter of choice. For this work a retroviral gene delivery system is 
established to obtain a knock-down of collagen XVI in dividing murine cells.  
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Analysis of the effects of the knockdown of collagen XVI in NIH3T3 fibroblasts 
With 2D-gelelectorphoresis differential expression of other proteins in the presence and 
absence of collagen XVI are analyzed, further identified with mass spectrometry, and 
approved in gene and protein expression by quantitative PCR and immunoblotting. 
Differences in cell proliferation and adhesion of NIH3T3 fibroblasts are determined by 
appropriate assays. 
Summary 
Aim of this work is to elucidate the role of collagen XVI during the progression of CD 
and to identify cellular mechanisms of ISEMF involving collagen XVI.  
Additionally, a gene-function analysis of collagen XVI is performed by establishment 
of a retroviral mediated knockdown model in NIH3T3 fibroblasts.  
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4. Material and methods 
 
The true method of knowledge is experiment. – William Blake 
 
4.1. Microbiological methods 
4.1.1. Cloning with TOPO-TA vector systems 
Topo TA cloning has been used for efficient cloning of PCR products with a Taq 
polymerase that has a non-template-dependent terminal transferase activity.  
 
Reagent Volume 
Fresh PCR product 0.5-4 µl 
Salt solution 1 µl 
Water; add to a total volume of 5 µl  
TOPO® vector  1 µl 
Final volume 5 µl 
 
Table 4-1: Ligation set up. 
 
The ligation set up (Table 4-1) was incubated at room temperature for 5 min and finally 
transformed into competent TOP 10 E. coli by heat shock as described in 4.1.4. 
 
4.1.2. Vector constructs for retroviral gene silencing using RNAi-ready 
pSIREN Retro Q 
Three individual shRNAs for collagen XVI were selected applying two algorithms 
provided by Clonetech, BD Biosciences and Invitrogen (Table 4-2). The hairpin loop 
containing shRNAs were generated and purchased from MWG, Germany.  
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shRNA 1 
Start: 326 
Target sequence gcaagaaggactcaagcta   
 
Top strand 
5'gatcc gcaagaaggactcaagctattcaagagatagcttgagtccttcttgctttttacgcgt g---- 3'  
 
Bottom strand 
5'aattc acgcgtaaaaaagcaagaaggactcaagctatctcttgaatagcttgagtccttcttgc g---- 3' 
shRNA 2 
Start: 571 
Target sequence ggaacacatggtacttgtt 
 
Top strand 
5'gatcc ggaacacatggtacttgttttcaagagaaacaagtaccatgtgttccttttttacgcgt g---- 3'  
 
Bottom strand 
5'attc acgcgtaaaaaaggaacacatggtacttgtttctcttgaaaacaagtaccatgtgttcc g---- 3' 
shRNA 3 
Start: 2059 
Target sequence agggtagttttggcgatac  
 
Top strand 
5'gatcc aggtagttttggcgatacttcaagagagtatcgccaaaactaccctttttttacgcgt g---- 3'  
 
Bottom strand 
5'aattc acgcgtaaaaaaagggtagttttggcgatactctcttgaagtatcgccaaaactaccct g---- 3' 
 
 
Table 4-2: shRNAs for collagen XVI silencing. 
 
4.1.3. Bacterial culture medium 
Culture medium  Concentrations Reagents  
LB-medium (pH 7.5) 
 
10 g/l 
5 g/l 
85 mM 
Bacto Trypton-extract (BD, Germany) 
Bacto yeast-extract (BD, Germany) 
NaCl (AppliChem, Germany) 
SOC-medium (pH 7.5)  Obtained from Invitrogen, Germany 
LB-agar  1.5 % (w/v) LB-medium containing  Bacto Agar 
(BD, Germany) 
 
Table 4-3: Bacterial culture medium components. 
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LB-medium was autoclaved and cooled below 50 °C before the antibiotic was added. 
LB-agar was prepared similarly by autoclaving LB-medium which contains appropriate 
amounts of powdered agar. Antibiotic was added prior to preparing agar plates under 
sterile conditions (Table 4-4). The culture plates were stored at 4 °C.   
Antibiotic Final concentration 
Ampicillin, Sigma, USA 100 µg/ml  
Kanamycin, Sigma, USA  25 µg/ml 
 
Table 4-4: Antibiotics for bacterial selection medium. 
 
4.1.4. Transformation of competent bacteria and cloning of cDNA fragments 
4.1.4.1. General transformation protocol 
Commercially available competent bacteria E. coli XL GOLD and TOP 10 were 
obtained from Stratagene (Netherlands) and Invitrogen (Germany), respectively. The 
bacteria were transformed and transformed colonies and bacteria stocks were stored in 
cryotubes at -80 °C (roti®store, Roth, Germany).  
Transformation was performed employing the heat shock treatment method. For this 
purpose 25 µl of bacterial suspension was mixed with the DNA solution and incubated 
on ice for 30 min. This mixture was placed into a water bath at 42 °C for 45 sec and 
immediately cooled on ice. The bacterial suspension was mixed with 500 µl SOC-
medium and placed at 37 °C with shaking (200 rpm) for 45 min. Aliquots of the 
suspension (50 µl and 100 µl) were plated on LB agar plates containing appropriate 
antibiotics and were incubated over night at 37 °C. Plates containing bacterial colonies 
were either stored at 4 °C until further use or single colonies were transferred to 5 ml 
antibiotic containing medium and incubated over night at  37 °C, 200 rpm shaking. The 
correct insertion of the DNA-fragment was approved by colony PCR as described in 
4.2.2, by final plasmid isolation (Qiagen Spin Miniprep Kit, according to the 
manufacturer’s protocol) and sequencing of the insert (performed at Geneart, Germany).  
 
4.1.4.2. Transformation with recombinant pSIREN-RetroQ Retroviral 
vector 
After ligation of the shRNAs into the linearized shRNA expression vector (RNAi-ready 
pSIREN retro Q plasmid expression vector system, Clonetech, BD, Bioscience) this 
vector system was transformed into 50 µl of E.coli K-12 competent cells (Fusion-Blue 
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competent cells, Clonetech, USA). After 30 min incubation on ice the cells were 
subjected to a heat shock for 45 sec at 42 °C in a water bath and placed back on ice. 
Transformation was performed at 37 °C for 1 hr shaking at 200 rpm after the addition of 
950 µl SOC medium. 50 µl of the transformation mix were plated on LB agar plates 
containing ampicillin (see antibiotics 4.1.3) and incubated overnight at 37 °C.  
 
4.2. Molecular biology methods 
4.2.1. Isolation and purification of plasmid DNA 
Plasmid DNA was isolated by using a silica membrane system commercially available 
from Qiagen, Germany. According to the manufacturer’s protocol for Spin Miniprep 
kits 5 ml of bacteria suspension were initially applied. Higher volumes up to 50 ml were 
purified with Qiagen Midiprep kit yielding up to 500 µg plasmid DNA. Plasmids for 
retroviral gene silencing were isolated by an endotoxin free plasmid extraction kit 
(NucleoBond Plasmid Maxi EF kit, Clonetech, BD Bioscience, USA) from an overnight 
culture of bacterial colonies in 4 ml of liquid LB medium which contained ampicillin. 
Positive clones were identified by restriction- and sequence analysis.  
 
4.2.2. Qualitative end-point Polymerase-Chain-Reaction (PCR) 
The amplification protocol comprised denaturation of the cDNA template at 95 °C for 
30 sec into single stranded DNA, specific annealing at 60 °C for 30 sec, and elongation 
at 72 °C for 10 min.  This cycle was repeated 30 – 35 times to obtain higher 
concentrations of the original cDNA template. The table below displays a set up for a 
50 µl PCR reaction using Hot Start Taq polymerase from Invitrogen, UK. 
Transformations were approved by colony PCR. In this case cDNA template was 
replaced by 1 µl bacterial suspension of an overnight culture.  
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Component  Concentration / volume 
cDNA template 10-100 ng / 1-20 µl 
10x PCR buffer 5 µl 
10 mM dNTP Mix 1 µl 
Primers (10 µM) 1 µl (each) 
Hot Start Taq polymerase 0.25 µl 
Water  Up to 50 µl 
Total volume 50 µl 
 
Table 4-5: PCR set up. 
 
4.2.3. Quantitative real-time Polymerase-Chain-Reaction (qPCR) 
Absolute and relative quantitative qPCRs were performed with SYBR Green Dye I with 
an ABI 7000 Prism Sequence detection system (Applied Biosystem, USA). Each primer 
was suspended in a concentration of 0.2 µM in SYBR Green master mix (Invitrogen, 
UK) and the reaction was carried out in 96-well plates with 5 µl diluted cDNA in a final 
volume of 25 µl. All primer pairs were run with the same amplification parameters 
which were repeated for 40 cycles. Denaturation took place at 95 °C for 9 sec and 
annealing at 60 °C for 1 min. Experiments were performed in triplicates for each 
sample. Murine and human primers were designed with Primer3 software and obtained 
from MWG-Biotech as listed in table 4-6 and table 4-7. 
 
4.2.3.1. Relative quantification 
Relative quantification was determined by the ∆∆Ct method using an internal calibrator 
and GAPDH or 18sRNA as endogenous control. The mean relative quantification (RQ) 
values are plotted semi-logarithmically. RQ values were calculated using the RQ study 
application v1.1 software (ABI Prism 7000 SDS software v1.1). 
 
4.2.3.2. Absolute quantification 
For absolute quantification a standard curve of serially diluted plasmids of known copy 
number (250 up to 5 x 107) was plotted and sample Ct values were used to determine 
the exact copy numbers of the genes of interest.  
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Primer ID Gene RefSeq 
number 
Amplicon 
(bp) 
Sequence 5’-3’ 
mColXVIa_FW_4533 Col XVI NM_028266 181 tacctccaggatgcagttcc 
mColXVIa_RV_4714    cacctttggtaccaggcagt 
mColXVIc_FW_559 Col XVI NM_028266 248 aaacacaccttccggaacac 
mColXVIc_RV_807    ctgggaggaagctgagacac 
m18sRNA_FW_448 18sRNA NR_03278 154 aaacggctaccacatccaag 
m18sRNA_RV_602    cctccaatggatcctcgtta 
mPpia_FW_313 PPIA NM_008907 126 agcatacaggtcctggcatc 
mPpia_RV_439    ttcaccttcccaaagaccac 
mMIF_FW_224 MIF NM_010798 106 atgacttttagcggcacgaa 
mMIF_RV_330    aggccacacagcagcttact 
 
Table 4-6: Murine oligonucleotides 
 
 
Primer ID Gene RefSeq 
number 
Amplicon 
(bp) 
Sequence 5’-3’ 
hColXVI_FW_4689 Col XVI M92642 97 gcctggtaccaaaggtgaaa 
hColXVI_RV_4786    catagcctggaggaccttga 
hCol_I_FW_2867 Col I NM_000088 172 acgtcctggtgaagttggtc 
hCol_I_RV_3038    accagggaagcctctctctc 
hGAPDH_2F_4531 GAPDH J04038 120 ctgacttcaacagcgacacc 
hGAPDH_2R_4650    ccctgttgctgtagccaaat 
hFN_FW_4326 Fibronectin BC117176 128 cccaactggcattgactttt 
hFN_RV_4453    ctcgaggtctcccactgaag 
 
Table 4-7: Human oligonucleotides 
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4.2.4. Approvement of correct insertion of cDNA fragments 
The plasmid cDNA inserts were characterized by isolating the cDNA fragment with 
restriction enzymes and application to an agarose gel containing ethidiumbromide to 
visualize the fragments. At least 200 ng of DNA were digested with 2 to 5 U of specific 
restriction enzymes in an appropriate buffer system for 2 hrs at 37 °C. 
Correct insertion of shRNA fragments was approved first by digestion with the enzyme    
MLU 1 which resulted in cleavage within the shRNA insert and second by sequence 
analysis.   
All restriction enzymes were purchased from NEB, UK. 
 
4.2.5. Agarose gel electrophoresis 
cDNA suspended in a loading buffer (6x agarose gel loading dye, Fermentas, Germany) 
was applied to agarose gels with varying agarose concentration from 1 % to 1.5 % (w/v) 
(Seakem Agarose, Biozym, Germany) in TAE buffer (0.8 mM Tris-Base, AppliChem, 
Germany; 0.8 mM acetic acid, Merck, Germany; 0.04 mM EDTA, AppliChem, 
Germany, pH 7.8) containing at least 20 mg/ml ethidiumbromide (Sigma, USA). An 
increasing concentration of agrose was referring to a smaller pore size and vice versa. 
Therefore, an electrophoretical size discrimination of cDNA amplicons was enabled. 
Comparison with a prestained marker (Gene Ruler, Fermentas, Germany) allowed 
control of the fragment size. The electrophoresis was perfomed at max. 90 V for 45 to 
90 min. Gels were visualized in a Chemi-Imager (Intas UV systems, Germany). 
 
4.2.6. Isolation, purification and quantitation of cDNA fragments 
cDNA fragments were isolated from agarose gels with Qiagen gel extraction kits 
(Qiaquick, QIAEX II, Qiagen, Germany) according to the manufacturer’s protocol. In 
order to remove nucleotides, enzymes or interfering salt concentrations the cDNA was 
purified using a PCR purification kit from Qiagen. Concentration of cDNA was 
determined by using an Eppendorf Biophotometer and evaluation of the absorption at 
260 nm / 280 nm. Absorption of 320 nm was used to determine protein contamination 
of the sample. An absorption of 1.0 at 260 nm refered to 50 µg/ml double stranded 
DNA. The ratio of absorption values of 260 nm to 280 nm of about 1.7 to 1.9 was 
considered without contamination protein residues. 
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4.2.7. Ligation and dephosphorylation of cDNA fragments 
cDNA fragments were inserted into cloning vectors applying T4 ligase (NEB, UK) at 
16 °C over night. cDNA and vector were usually mixed in molar relations of 1:1 up to 
5:1 using   2.5 U T4 ligase with appropriate buffers in a 20 µl set-up.  
The ligation procedure is often disturbed by insert-oligomer formation or re-ligation of 
the linearized vector ends. This process can be minimized by incubation with alkaline 
phosphatase (CIP, calf intestine phosphatase, Roche, Germany) which digests the 5’-
phosphate ends and therefore inhibits a re-ligation by T4 ligase.  
 
4.2.8. Ligation of hairpin structures (shRNA) for retroviral gene silencing 
To obtain the hairpin structure 100 µM of top and bottom strands, shRNAs were mixed 
equally and incubated for 30 sec at 95 °C and were annealed for 2 min at sequential 
temperatures of 72 °C, 37 °C, and 25 °C. 0.5 µM of annealed strands of each shRNA 
were ligated separately into 25 ng/µl linearized shRNA expression vector (RNAi-ready 
pSIREN retro Q plasmid expression vector system, Clonetech, BD, Bioscience, Fig. 4-
3) using 400 U/µl T4 DNA ligase in the presence of 1.5 µl of 10x T4 DNA ligase buffer 
in a total reaction volume of 15 µl. After 3 hrs incubation at room temperature 2 µl of 
the ligation products were transformed into 50 µl of E.coli K-12 competent cells 
(Fusion-Blue competent cells, Clonetech, USA). 
 
4.2.9. RNA isolation 
RNA was isolated with Qiagen Rneasy Mini Kit, based on affinity columns from either 
freshly isolated or frozen (-80 °C) cells according to the manufacturer’s protocol.  
RNA content and purity were determined at 260 nm/280 nm. An adsorption value at 
260 nm of 1.0 refered to 40 µg/ml single stranded RNA. The ratio of adsorption values 
of 260 nm to 280 nm was optimal at about 1.8 to 2.0 and guaranteed pure RNA. 
 
4.2.10. Reverse transcription 
Up to 5 µg RNA was conversed to cDNA using 500 ng/ml oligo dT primers and 10 mM 
dNTPs which were heated to 65 °C and quickly chilled on ice. First strand buffer, 0.1 M 
DTT, and RNAse OUT (40 U/rct) were mixed and added to the RNA-mixture and 
incubated for 2 min at 42 °C. First strand was synthesized after the addition of 200 U of 
SuperScript II enzyme (Invitrogen, UK) for 50 min at 42 °C. The reaction was 
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inactivated for 15 min at 70 °C and the cDNA was stored in aliquots until further use in 
polymerase chain reaction at -20 °C.  
 
4.3. Protein biochemistry 
4.3.1. Protein quantification 
Protein content was determined using the BCA method according to Smith et al. 1985. 
This quantification method is based on the chemical biuret reaction. Proteins reduce 
Cu2+-ions to Cu+-ions under alkaline conditions. Bicinochoninacid (BCA; 2, 2’-
Bichinolin-4, 4’-dicarbonacid-disodiumsalt, Pierce, USA) acts in a Cu+ complexion. 
The purple complex adsorbs at 562 nm and detection of this adsorption maximum is 
related to protein concentration.  
10 µl of the sample and a BSA standard solution (0 – 250 µg/ml in water) were 
separately added to 200 µl of BCA reagent. The final mixture was incubated for 30 min 
at 60 °C in a waterbath. The diluent of the sample served as blank. The extinction of the 
samples was determined in a photometer (Biophotometer, Eppendorf, Germany) at 560 
nm and converted via linear regression of the BSA standard curve to protein 
concentration in ng/µl.  
 
4.3.2. Protein precipitation 
4.3.2.1. TCA precipitation 
In order to concentrate proteins, the solution was incubated on ice for 20 min with a 
final concentration of 0.14 % (w/v) Triton X-100 (Sigma, USA) and 15.5 % (w/v) 
trichloric acid (TCA, Roth, Germany). Centrifugation with 18,000 x g for 20 min at 
4 °C resulted in a protein pellet that was washed two times with pre-chilled acetone 
(Fischar, Germany). After air-drying the pellet was resuspended in an appropriate 
volume of sample buffer and protein content was quantified. 
 
4.3.2.2. Methanol-chlorophorm precipitation 
500 µl of protein sample were mixed with equal volumes of methanol and 0.4 x 
volumes of chloroform. This solution was thoroughly vortexed and centrifuged for 10 
min at 15,000 x g. The mixture was separated into an upper aqueous and a lower 
organic phase divided by an interface containing the protein. The upper phase was 
removed and the residual sample was washed twice with 500 µl methanol and 
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centrifuged. After air-drying, the pellet was resuspended in an appropriate volume of 
sample buffer and protein concentration was determined with the BCA method. 
 
4.3.3. SDS PAGE according to Lämmli 
The discontinuous sodium-dodecyl-sulfate polyacrylamid-gelelectrophoresis (SDS-
PAGE) according to Lämmli, 1970 was used to discriminate heterogenous protein 
samples comprising different protein fractions. The proteins were separated for 
immunoblotting of collagen XVI in discrete gradient gels with a polymer content of 
4.5 % up to 15 %. For 2D-gelelectrophoresis gels an acrylamide concentration of 10 % 
was used. For other applications polymer content was adapted according to the 
molecular weight of the sample protein. In all cases a 4.5 % stacking gel was poured on 
top of the resolving gel. Concentrations of the ingredients are listed in table 4-8. The gel 
run was performed under cool conditions at approximately 4 °C at a maximum current 
of 20 mA. A pre-stained protein marker was always co-separated to determine the 
molecular weight of the sample (Precision Plus™ Protein All Blue Standard, Biorad). 
 
Solutions Concentration of ingredients 
Resolving gel buffer 1.5 M Tris/HCl, AppliChem, Germany pH 8.8 
0,4 % (w/v) SDS, Roth, Germany 
Stacking gel buffer 0.5M Tris/HCl, AppliChem, Germany pH 6.8 
0.4 % (w/v) SDS, Roth, Germany 
Acrylamide stock solution 30 % (w/v) bisacrylamide, Roth, Germany 
TEMED 100 % triethylmethylethylendiamin, AppliChem, 
Germany 
APS 10 % (w/v) ammoniumpersulfate (APS, Serva, 
Germany) in water 
Sample buffer 0.1 M Tris/HCl, AppliChem, Germany, pH 6.8 
1 % (w/v) SDS, Roth, Germany  
20 % (v/v) glycerol, AppliChem, Germany 
5 % (v/v) ß-mercaptoethanol, Sigma, USA 
0.01 % (w/v) bromphenol blue, Sigma, USA 
 
Table 4-8: Buffer concentrations for SDS-PAGE according to Lämmli.  
 
Material and methods   
 - 37 -
4.3.3.1. Sample preparation for SDS PAGE 
The protein sample had to be exempted from interfering ions and was therefore 
precipitated and spiked with sample loading buffer. The reduction of disulfide bonds 
was obtained by heating the samples with ß-mercaptoethanol in a final concentration of 
5 % (v/v) for 5 min at 95 °C. 
 
4.3.3.2. Protein detection in SDS PAGE 
Proteins were stained after electrophoretic separation either with Coomassie Blue or 
silver nitrate or were prepared for blotting on a nitrocellulose membrane for 
immunodetection. 
 
4.3.3.2.1. Coomassie Blue staining 
The staining solution contained 0.1 % (w/v) Coomassie Brilliant Blue R-250 (Serva, 
Germany) in 25 % (v/v) methanol (Roth, Germany) and 10 % (v/v) acetic acid (Merck, 
Germany). Background staining was removed sequentially by two destaining solutions 
containing first 50 % (v/v) methanol, 10 % (v/v) acetic acid and second 10 % (v/v) 
methanol and 10 % (v/v) acetic acid, respectively. 
 
4.3.3.2.2. Silver staining 
The silver staining of polyacrylamid gels was perfomed using the following staining 
solutions listed in table 4-9.  
 
Solutions Concentrations of ingredients 
Fixing solution 6 mM sodium thiosulfate (Na2S2O3 x 5H2O), 
AppliChem, Germany 
30 % (v/v) ethanol , Roth, Germany 
400 mM sodium acetate, AppliChem, Germany 
200 µl acetic acid, Merck, Germany 
0.25 % (v/v) glutardialdehyde, Merck, Germany 
Silver nitrate solution 6 mM silver nitrate, Fluka, Germany 
0.019 % (v/v) formaldehyde, AppliChem, 
Germany 
Developing solution 2.5 % (w/v) sodium carbonate, AppliChem, 
Germany 
  Material and methods 
 - 38 -
0.015 % (v/v) formaldehyde, AppliChem, 
Germany 
Stop solution 7 % (v/v) acetic acid, Merck, Germany 
 
Table 4-9: Staining solutions for silver staining of polyacrylamide gels 
 
The gels were fixed for 15 min in fixing solution on a shaker at 50 rpm. After several 
washing steps with distilled water the silver nitrate solution was allowed to incubate for 
additional 15 min. The protein bands were finally visualized with alkaline developing 
solution that reduced silver ions. The intensity of the staining was controlled by a stop 
solution. 
 
4.3.4. Protein transfer for immunoblotting 
Proteins were electrotransferred to a nitrocellulose membrane (Protran, Schleicher & 
Schuell, Germany) with a semi-dry blotter (MultiBlot-transfer, MBT, Germany) in a 
sandwich of three layers whatman paper (Schleicher & Schuell, Germany), 
nitrocellulose membrane, polyacrylamide gel and again three layers of whatman paper. 
Per cm² of nitrocellulose membrane 0.8 mA current was applied for 60 min up to 
75 min according to the fragment size of the protein. Prior to transfer, Whatman paper 
and nitrocellulose membrane were soaked in blotting buffer containing 50 mM Tris 
(AppliChem, Germany), 380 mM glycine (AppliChem, Germany), 0.1 % (w/v) SDS 
(Roth, Germany), 10 % (v/v) methanol (Merck, Germany). After blotting, transfer of 
proteins was confirmed by a reversible Ponceau red staining of the membrane with a 
0.2 % (w/v) Ponceau S solution in 3 % (v/v) TCA (both Sigma, Germany). 
 
4.3.5. Immunoblotting (Western Blotting) 
After protein transfer to a nitrocellulose membrane unspecific binding sites were 
blocked with a buffer containing 5 % (w/v) dry milk powder (Roth, Germany) in PBST 
(0.1 % (v/v) Tween 20 in PBS) for 1.5 hrs at rt. After a short washing step in PBST the 
membrane was incubated either at 4 °C over night or at rt for 2 hrs with the primary 
antibody diluted in blocking solution. Unspecific bound antibody was removed in three 
washing steps each for 10 min in PBST. The appropriate peroxidase coupled secondary 
antibody was also incubated in blocking solution for 90 min at rt. Washing steps were 
repeated as described for the primary antibody. Protein bands were detected by 
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incubating the membrane with ECL reagent (Pierce, USA) for 1 min. Wrapped in clear 
foil, the luminescent signal was detected by application of an x-ray film for 10 sec to 
5 min (Amersham, UK). If StrepII-Tag was to be detected, dry milk powder was 
replaced by the same amounts of bovine serum albumin (BSA, Biomol, Germany) for 
blocking and all following incubation steps. This StrepTag interacts with high levels of 
biotin in milk and therefore protein detection would be disturbed. 
 
4.3.6. Immunostaining 
4.3.6.1. Paraffin embedding, tissue mounting and sectioning 
Tissue samples were fixed in 4 % (w/v) PFA in PBS over night and washed thoroughly 
in PBS. Placed in plastic embedding cassettes (Tissue-Tek, Miles, USA) samples were 
dehydrated in an ascending ethanol series (Roth, Germany) from 50 % (v/v) to 96 % 
(v/v). According to their size, the samples were incubated for 2-6 hrs in each alcohol 
solution at 4 °C. Subsequently the samples were incubated twice for 2-6 hrs in 
isopropanol at 4 °C. The alcohol was exchanged by an isopropanol-paraffin mixture 
(1:1) for 24 hrs at 60 °C and the samples were transferred for at least 24 hrs to pure 
paraffin at 60 °C. The tissue was finally embedded in paraplast (Paraplast plus, Roth, 
Germany) using a paraffin embedding station (Leica, EG 1150H and Leica EG 1150 C, 
Leica, Germany) and mounted on section blocks for preparing 4 µm sections with a 
Leica microtome (Leica Jury RM2055, Leica, Germany). 
 
4.3.6.2. Cryo embedding, tissue mounting and sectioning 
Tissue samples were embedded in Tissue-Tek® (Sakura Finetek USA) and frozen in 
liquid nitrogen and cross-sectioned with a cryo-microtom (Mikrom® HM 500 OM, 
Germany) in 10 µm sections. 
 
4.3.6.3. Immunohistochemistry  
Paraffin sections were deparaffinized for 30 min at 50 °C in a humid chamber and 
sequentially subjected to 10 min incubation in Rotihistol (Roth, Germany), 5 min in 
100 %, 96 % (v/v), 70 % (v/v), 50 % (v/v) ethanol (Roth, Germany) and finally 10 min 
in PBS. The procedure of fixation may lead to masking of sample epitopes; to render 
these epitopes accessible to the primary antibody, physical and chemical barriers are 
removed by a process called unmasking. For that purpose the samples were incubated 
with protease XXIV (Sigma, USA, 0.05 % (w/v) in PBS) and hyaluronidase (Sigma, 
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USA, 0.1 % (w/v) in acetate buffer (pH 6)) for 6 min, respectively 60 min at 37 °C in a 
humid chamber. Each enzyme was washed thoroughly from the slides with PBS before 
unspecific binding sites were blocked with 5 % (v/v) normal goat serum (Dako, 
Denmark), 1 % (w/v) BSA (Biomol, Germany) and protease inhibitor (Complete Mini, 
1:5, Roche, Germany) in PBS for 60 min at 37 °C. Appropriate first antibodies were 
diluted in blocking buffer and incubated over night at 4 °C. After washing with PBS, the 
secondary antibody was applied diluted in PBS and incubated at 37 °C for 1 hr.  
Tyramide signal amplification (TSA™) was applied in some cases to enhance weak 
immuno reactive signals. This enzyme-mediated detection method utilizes the catalytic 
activity of horseradish peroxidase (HRP) to generate higher density labelling. For signal 
intensification endogenous peroxidase was quenched for 60 min at room temperature in 
quenching buffer followed by regular blocking and incubation with the first antibody. A 
secondary biotinylated antibody was applied diluted in blocking solution for 60 min 
followed by the HRP conjugate (1:100 in blocking solution) for 45 min at rt. For 
tyramide labeling the Alexa Fluor 488 tyramide working solution was diluted according 
to the manufacturer’s protocol in amplification buffer and incubated for 10 min. All 
reagents were purchased from Molecular Probes, USA. Nuclei were counter-stained 
with DAPI (Molecular Probes, USA) for 10 min and the slides were washed again with 
PBS before they were mounted with fluorescence mounting medium (Dako, Denmark). 
Cryosections were fixed in ice-cold acetone (Fischar, Germany) for 10 min at 4 °C. 
Blocking and further staining procedures were performed as described above.  
 
4.3.6.4. Immunocytochemistry  
For immuno staining, cells were fixed for 10 min either in ice-cold acetone (Fischar, 
Germany) or in 4 % (w/v) PFA (AppliChem, Germany) with 0.1 % (v/v) Tween 20 
(Sigma, USA) in PBS. Fixing solution was removed by washing with PBS three times 
for 5 min each. Before blocking unspecific binding sites with a solution of 1 % (v/v) 
normal goat serum (Dako, Denmark) in PBS, auto-fluorescence was quenched using 
100 mM NH4Cl in PBS for 10 min. This step was performed for phalloidin/vinculin 
staining only. The blocking was followed by incubation with the first antibody diluted 
in blocking buffer either over night at 4 °C or 1 hr at 37 °C. The secondary antibody, 
diluted in blocking buffer was left on the slides for 1 hr at 37 °C. The nuclei were 
stained with DAPI for 10 min and stress fibers with phalloidin for 30 min at 37 °C (both 
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Molecular Probes, USA). Slides were mounted in fluorescence mounting medium 
(Dako, Denmark). 
All histological incubation steps were performed in humid chambers. The stained 
structures were visualized with confocal laser scanning microscopy (C1 confocal 
microscope, C4 camera and software Nikon, Germany). In case of immunocytochemical 
staining of focal adhesion contacts and stress fibres, the number of focal adhesion 
contacts and length were determined in five independent fields of view in vinculin/F-
actin fluorescence stainings of four patients per inflammation stage and depicted in FC 
per cell and µm per contact.  
 
4.3.6.5. Immunocytochemistry detecting α1 integrin chain 
Glass cover plates were coated with poly-L-lysine (5 µg/ml, Sigma, USA), collagen I 
(10 µg/ml, Sigma, USA), and recombinant collagen XVI (10 µg/ml and 30 µg/ml) at 
4 °C over night as described in 4.5.6. After washing with PBS, the cover plates were 
blocked with 0.1 % BSA (Biomol, Germany) in PBS for 1 hr at rt. ISEMF were 
suspended in DMEM (Invitrogen, UK) culture medium with cell specific additives and 
w/o 0.1 mM MnCl2 (Merck, Germany). The cells were seeded in a density of 15,000 
cells/ml onto the substrate-coated glass plates. After incubation for 6 hrs at 37 °C under 
5 % CO2 cells were washed with PBS, supplemented with 2 mM MgCl2 and 2 mM 
CaCl2, w/o 0.1 mM MnCl2 and fixed with 4 % PFA (AppliChem, Germany) in the same 
buffer for 7 min at rt. After triple washing with PBS cells were blocked and 
permeabilized in blocking buffer containing 0.5 % (v/v) Tween 20 (Sigma, USA), 2.5 % 
(v/v) methanol and 5 % (v/v) normal goat serum (Dako, Denmark) in PBS for 1 hr. 
ISEMF were stained with rabbit anti-vinculin antibody (V4139, Sigma, USA) and 
mouse anti-α1 integrin mAb (MAB1973Z, Chemicon, USA) diluted in blocking buffer 
1:50 and 1:500, respectively, for 2 hrs. Primary antibodies were detected with 
AlexaFluor 488-conjugated anti-(rabbit IgG) antibody and AlexaFluor 568-conjugated 
anti-(mouse IgG) antibodies (both Molecular Probes, USA). Secondary antibodies were 
diluted 1:500 in blocking buffer and incubated for 2 hrs. Incubation with primary and 
secondary antibodies was followed by three washing steps with PBS. Nuclei were 
stained with 300 nM DAPI (Molecular Probes, USA) for 10 min. Finally, cells were 
washed in PBS and mounted in Fluoromount mounting medium (Dako, Denmark). 
Pictures were taken with a confocal laser scanning microscope (Nikon, C1 confocal 
microscope and Nikon C4 camera and software, Germany). 
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4.3.6.6. Flow cytometric analysis (FACS) 
Primary ISEMF from CD patients were harvested with accutase (PAA, Germany) and 
the cell pellet was resuspended in blocking solution containing 1 % (w/v) BSA (Biomol, 
Germany) and 1 % (v/v) normal goat serum (Dako, Denmark) in PBS for 30 min at 
4 °C. The cell suspension was incubated with antibodies and with the corresponding 
isotype control, which was diluted in blocking buffer for 1 hr at 4 °C. Cells were 
washed with PBS and resuspended with the appropriate secondary antibody (fluorescent 
dye conjugated) for 1 hr. After washing, cells were resuspended in 500 µl PBS for 
FACS (FACScanto, BD, USA). Data analysis was performed with WinMDI 2.8 
software.  
 
4.3.7. Protein A purification of polyclonal antibodies 
Here, the ability of protein A, a 42 kDa polypeptide derived from the cell wall of 
Staphylococcus aureus to specifically bind to the Fc region of various immunoglobulins 
was utilized. The antibody purification was achieved by binding the antibody at neutral 
to high pH and by elution upon a shift to low pH using Vivapure Protein A Mini spin 
columns from Vivascience AG, Germany. The equilibrated columns were loaded with 
100 µl of antiserum diluted with 300 µl of binding buffer (0.5 M sodium chloride, NaCl, 
10 mM potassium phosphate, pH 7.4, both AppliChem, Germany) and centrifuged at 
800 x g for 5 min. The column flow-through was reloaded and the process was repeated 
five times. Afterwards the columns were washed once with 400 µl binding buffer. The 
antibody was eluted using a 0.1 M glycine/HCl buffer (pH 2.8, AppliChem, Germany) 
and centrifuged at 800 x g for 5 min. Immediately after elution, the antibody solution 
was neutralized with neutralization buffer (1 M Tris (AppliChem, Germany), pH 9.0). 
The solution was concentrated to 100 µl using Vivaspin 2 columns with a 10 kDa 
molecular weight cut off and conserved with 0.02 % (v/v) sodium azide (Sigma, USA). 
Purified antibody was stored at 4 °C.     
 
4.3.8. Protein extraction 
Cell lysis was performed using RIPA buffer (Sigma, USA) containing protease inhibitor 
(1 tablet per 6 ml buffer, complete mini, Roche Applied Science, Germany). Confluent 
cell layers were trypsinized and washed with PBS. After centrifugation, the cell pellet 
was resuspended in RIPA buffer and incubated on ice for 30 min with interim 
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vortexing. Insoluble material was removed by centrifugation at 10,000 x g for 10 min. 
The protein content of the cell lysate was determined using bicinochoninic acid protein 
assay (BCA, Pierce, USA) and stored at -20 °C until further use.  
 
4.3.9. 2D-gelelectrophoresis 
The two-dimensional gelelectrophoresis separates proteins according to their isoelectric 
point (IEP) and their molecular weight. The first dimension constitutes the isoelectric 
focussing (IEF). Here, the sample is applied to a polyacrylamid strip (IPG), where a pH 
gradient is immobilized. After application of current, the proteins move along the gel 
and accumulate at their isoelectric point. At this point the overall charge of the protein 
is neutral. In the second dimension the proteins are separated according to their size by 
SDS-PAGE.  
 
4.3.9.1. Sample preparation, rehydration and sample loading 
Aliquots of lysis buffer were thawed and protease inhibitor (complete mini, Roche, 
Germany) was added in a ratio of 1:20. The prepared lysis buffer was used once and 
additional freeze-thaw-cycles were avoided.  
Cells were harvested using trypsin/EDTA (PAA, Germany) and washed with PBS. Per 
0.8 x 106 cells 60 µl of lysis buffer was added. Suspended cells were vortexed and kept 
on a shaker for 15 min at 4 °C. Finally, lysed cells were centrifuged for 10 min at 
10,000 x g at 4 °C and the clear supernatant was aliquoted and frozen at -80 °C for 
further usage after BCA protein quantification.  
Rehydration and incubation of the sample, immobilized on an IPG strip were combined 
in one step. For that purpose, total protein with a concentration of 300 µg was diluted in 
rehydration buffer to a final volume of 125 µl. For a better orientation 2.5 µl of 2D-
SDS-PAGE protein standard (BioRad, Germany) was added. Electrodes were prepared 
with pre-wetted electrode wicks and the sample mix was applied without air bubbles 
into an incubation chamber. The protective film was removed from the IPG strips and 
these strips were placed with the acrylamid side towards the sample. To avoid drying of 
the protein sample mineral oil covered the strips. The rehydration and focussing was 
performed in a Protean IEF Cell (BioRad, Germany) according to the following 
protocol. Buffer components and concentrations are listed in table 4-11.  
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4.3.9.2. Isoelectric focussing 
Isoelectric focussing was performed according to a protocol (table 4-10) recommended 
by the manufacturer.  
 
Step 
Incubation of the protein; ramp voltage 
Rehydration of a 7 cm IPG gel stripe at 10 °C 
Active rehydration at 10 °C (12 hrs) 
Pre-focussing at 250 V (15 min) 
Focussing up to 4000 V (2.5 hrs) 
Hold at 4000 V until 22,000 Vhrs are reached 
Hold at 500 V to avoid diffusion 
 
Table 4-10: Program of isoelectric focussing (IEF) 
 
4.3.9.3. Equilibration of IPG strips for SDS-PAGE 
After focussing the strips were washed thoroughly with water to remove mineral oil 
residues. The strips were subsequently incubated in equilibration solution containing 
1 % (w/v) DTT (AppliChem, Germany) and 260 mM iodacetamid (BioRad, Germany). 
Both solutions were freshly prepared and used to avoid striation. The strips were placed 
bubble free into SDS gels together with 20 µl of loading dye and fixed with pre-warmed 
agarose (BioRad, Germany). The gels were run with 20 mA per gel for about 1 hr. The 
gels were finally stained with coomassie brilliant blue or with silver nitrate solution and 
scanned for further analysis with PD Quest software (BioRad, Germany). 
 
 
Lysis buffer 
9 M Urea 
 1 % (w/v) DTT 
 2 % (w/v) CHAPS 
 0.8 % (v/v) Bio-lyte, pH 3-10 (BioRad, Germany) 
 5 mM  Complete mini (Roche, Germany) 
Rehydration buffer 8 M  Urea 
 10 mM  DTT 
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 1 % (w/v) CHAPS 
 0.25 %  Bio-lyte, pH 3-10 (BioRad, Germany) 
Equilibration buffer 6 M Urea 
 30 % (v/v) Glycerol 
 2 % (w/v) SDS 
  in 0.05 M Tris / HCl pH 8.8 
 
Table 4-11: Buffer concentrations for lysis, rehydration and equilibration used in 2D-
gelelectrophoresis 
 
4.4. Scanning electron microscopy (SEM) 
The scanning electron microscope images a sample surface by scanning it with a high-
energy beam of electrons. The resolution is limited to 2 nm.  
Cells were subjected to scanning electron microscopy to visualize their adhesion 
properties. For this purpose the cells (10,000 cells/cm²) were left to adhere in their 
culture medium for 3 hrs on pre-coated glass slides and were fixed for 20 min using 
2.5 % (v/v) glutaraldehyde (Merck, Germany). The samples were subsequently 
dehydrated in ascending ethanol series (Roth, Germany) from 30 % (v/v) to 100 % (v/v) 
three times each for 20 min. Since air drying causes deformation of structure due to 
surface tension originated at the phase boundary when liquids evaporate, the samples 
were critical point dryed (CPD). The medium in this procedure is liquid CO2 and the 
drying takes place above the critical point of this liquid medium at 73.8 bar and 31 °C. 
Dehydration medium and inter-medium in the critical-point-dryer (Balzers Union, 
Liechtenstein) was 100 % ethanol (Roth, Germany). The samples were kept in dry 
atmosphere in a desiccator after CPD until they were analyzed with scanning electron 
microscopy. 
Samples were gold-sputted and visualized by a Hitachi S-2700 scanning electron 
microscope and evaluated using Digital Image Processing system 2.5 software. 
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4.5. Cell culture methods 
4.5.1. Transfection 
4.5.1.1. General transfection protocol 
Transfection was carried out using Lipofectamine 2000 (Invitrogen, UK), a lipid-based 
transfection reagent. Cells were seeded at a density of 500,000 cells per well in a 6-well 
plate. Each reaction was incubated for 5 min with 5 µl Lipofectamine 2000 and 15 µl 
culture medium without FCS. cDNA (~ 0.5 µg/rct) was separately prepared with FCS-
free medium up to a volume of 20 µl. Both solutions were gently mixed and incubated 
for 15 min at rt. Afterwards, the reaction volume was added to the cells together with 
usually applied culture medium and were incubated for 24 hrs at 37 °C and 5 % CO2. 
After this time, medium was replaced by selection medium containing an appropriate 
antibiotic in a concentration previously determined in a kill curve for non-transfected 
cells. Transfection was controlled by transfecting the empty vector and by applying 
selection medium to non-transfected cells. By the time all non-transfected cells have 
died upon antibiotic application, resistent clones were isolated and further cultivated.  
 
4.5.1.2. Transfection protocol for generation of shRNA expression 
retrovirus 
Endotoxin-free retroviral vector, containing shRNAs, was transfected into the EcoPak 
293-2 packaging cell line with Lipofectamine 2000 (Invitrogen, UK) as described 
above. After 24 hrs 6 µg/ml of puromycine (Biomol, Germany) was added. The 
antibiotic containing medium was renewed three times a week for a total of 10 days. 
Puromycin resistent clones were selected and transferred to a 25 cm² flask and further 
passaged to obtain enough transfected cells for transduction experiments. Transfected 
cells were also harvested for long time storage in liquid nitrogen and for transduction 
experiments (described in 4.5.4). For transduction, the culture medium containing virus 
was collected after 48 hrs from confluent flasks.  
 
4.5.2.  Titration of antibiotic stocks (kill curve) 
Prior to application of puromycin in order to establish stable cell lines, selection agent 
stocks had to be titrated to determine the optimal concentration for selection with the 
chosen cell line. It is also important due to lot-to-lot variation of agent efficiency. 
50,000 non-tranfected cells per well were plated in 6-well plates containing the culture 
medium plus increasing amounts of puromycin (0, 1.0, 2.5, 5.0, 7.5, and 10.0 µg/ml). 
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The cells were incubated for 10 days to 14 days and the selection medium was replaced 
every three days. For selecting stable transformants, the lowest concentration that 
induces massive cell death in about 5 days and kills all the cells within two weeks was 
used.  
 
4.5.3. Virus titer determination 
For virus titer determination 50,000 cells per well were seeded in a 6-well plate and 
cultured over night. The next day virus was added in a 10-fold serial dilution in 
complete medium containing 6 µg/ml polybrene. After 24 hrs of cultivation puromycin 
was applied in a previously determined concentration (see 4.5.2). Medium with 
antibiotic was renewed every second day. Control wells which contained non-
transduced cells were treated with the same antibiotic concentration. After these cells 
had died the colonies of cells per well (colony forming units, cfu) for different virus 
concentrations were counted and the virus titer was determined according to this 
formula: 
 
4.5.4.  Transduction of NIH3T3 cells 
For transduction, culture medium containing shRNA expressing virus (without selecting 
antibiotic) was collected after 48 hrs of culture from confluent flasks. Virus titer was 
determined as described above and virus medium, characterized by at least 105 CFU 
was used for transduction. NIH3T3 cells ranging from 5 x 104 to 1 x 105 cells were 
seeded per well containing 1 ml of fresh or frozen (-80 °C) filtered (0.45 µm filter, 
Millipore, Germany) virus medium plus 6 µg/ml polybrene (Sigma, USA) and 
incubated over night at 37 °C and 5 % CO2. Subsequently 1 ml fresh NIH3T3 growth 
medium (described in 4.5.5.2.1) containing puromycin in a final concentration of 
5 µg/ml was added. The remaining colonies were transferred to larger flasks and further 
cultivated. Finally, cells were harvested by trypsin digestion and used for gene and 
protein analysis. 
 
 
 
cfu x dilution factor = cfu/ml 
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4.5.5. Cell source, preparation and culture conditions of the utilized cells 
The table below lists all utilized cells, further described in this chapter. 
 
Primary cells Cell lines  
human murine human 
ISEMF NIH3T3 o CCD18Co 
o EcoPack2-293 
o HEK 293 EBNA 
o HEK 293 EBNA Strep16 
 
Table 4-12: Cell types 
 
4.5.5.1. Primary cells – human intestinal subepithelial myofibroblasts 
(ISEMF) 
ISEMF were isolated from intestinal tissue, obtained from Crohn’s Disease (CD) 
patients showing different inflammatory affection and histology. The degree of 
inflammation was graded endoscopically according to the following parameters shown 
in table 4-13. Determination of inflammation stage was also performed by hematoxylin 
and eosin staining and counting of neutrophils, eosinophils and lymphocytes.  
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201 ♂ - Colon ascendens x x x x  x x 
202 ♀ - Colon transversum  x  x 
 
x  
206 ♀ - Colon ascendens x x  x  x x 
207 ♂ - Colon ascendens x x x x  x x 
210 ♂ - Colon ascendens x x x x  x x 
68 ♂ - Colon transversum      x 
60 ♂ + Colon transversum      x 
30 ♂ + Caecum x x  x x x 
63 ♂ + Sigma x x x x x x 
169 ♀ + terminal Ileum x x  x   
24 ♂ + Rectum x x x x x x 
35 ♂ + Sigma  x x  x  
62 ♂ ++ Colon ascendens x x x x  x x 
32 ♂ ++ Ileocaecum x x x x x x 
171 ♀ ++ colon x x x x   
185 ♂ ++ terminal Ileum  x  x  x  
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167 ♀ ++ Ileocaecum x     x 
192 ♂ ++ Sigma x x  x x x 
69 ♀ +++ Rectum x x   x x 
111 ♀ +++ Sigma x   x   
131 ♀ +++ terminal Ileum  x  x   
190 ♀ +++ Sigma x x x x x x 
197 ♂ +++ Caecum x x x x x  
209 ♂ +++ terminal Ileum x x x x  x x 
 
Table 4-13: Degree of inflammation, region of resection and relation of analyzed 
parameter of patient cell biopsies. 
[-] non-inflamed (without pathological findings), [+] slightly inflamed (single small 
aphthous lesions), [++] inflamed (multiple aphthous lesions and small ulcers), [+++] 
highly inflamed (large ulcerous lesions) 
 
Mucosal samples were completely denuded of epithelial cells by treatment with 2 mM 
EDTA (AppliChem, Germany) at 37 °C for 20 min and myofibroblasts were isolated 
according to established protocols  and characterized by anti-vimentin and anti-vinculin 
staining (Mahida et al., 1997; Rogler et al., 2001). Cells were maintained in SM-GM 
(Table 4-17). 
 
DMEM (Dulbecco’s modified eagle’s medium), Gibco, BRL, UK 
10 % (v/v) FCS, Invitrogen, UK 
1 % (v/v) penicillin-streptomycin, PAA, Germany 
1 mM sodium pyruvate, Sigma, USA 
1 % (v/v) non essential amino acids, Gibco BRL, UK 
50 mg/ml gentamicin, Sigma, USA 
8 µg/ml ciprofloxacin, Bayer, Germany 
1 µg/ml amphotericin, Bristol-Meyers Squibb, USA 
 
Table 4-14: Intestinal subepithelial myofibroblast growth medium (SM-GM). 
 
4.5.5.2. Cell lines 
4.5.5.2.1. Murine cell lines 
NIH3T3 fibroblasts (American Type Culture Collection (ATCC), no. CRL 1658) have 
been established from primary mouse embryonic tissue cultured by a designated 
protocol, so-called ‘3T3 protocol’. The spontaneously immortalized cells with a stable 
growth rate were established after 20-30 generations in vitro. 
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DMEM F-12, Gibco BRL, UK 
10 % (v/v) FCS, Invitrogen, UK 
1 % (v/v) penicillin-streptomycin, PAA, Germany 
 
Table 4-15: NIH3T3 growth medium (NIH-GM). 
 
4.5.5.2.2. Human cell lines 
4.5.5.2.2.1. CCD18Co  
These cells were originally derived from a colonic mucosal biopsy of a 2-month old 
female human infant and obtained from ATCC, no. CRL-1459. 
 
EMEM (Eagle’s minimal essential medium), Cambrex, Belgium 
10 % (v/v) FCS, Invitrogen, UK 
1 % (v/v) penicillin-streptomycin, PAA, Germany 
1 mM sodium pyruvate, Sigma, USA 
0.1 mM non essential amino acids, Gibco BRL, UK 
 
Table 4-16: CCD18Co growth medium (CCD18Co-GM). 
 
4.5.5.2.2.2.  EcoPack2-293 
The adherent BD EcoPack2-293 packaging cell line (BD, Bioscience, USA) were 
derived from the human embryonic kidney (HEK 293) cell line and was designed for 
rapid, transient and also stable production of ecotropic retrovirus. Virus produced by 
these cells possesses an ecotropic envelope (gap70) and was therefore only able to 
infect mouse and rat cells.  
 
DMEM F-12, Gibco BRL, UK 
10 % (v/v) FCS, Invitrogen, UK 
1 % (v/v) penicillin-streptomycin, PAA, Germany 
4 mM L-glutamine, PAA, Germany 
1 mM sodium pyruvate, Sigma, Germany 
 
Table 4-17: EcoPack2-293 growth medium (ECO-GM). 
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4.5.5.2.2.3.  HEK 293 EBNA 
The HEK 293 EBNA cell line is a human embryonal kidney cell line derived from HEK 
293 (ATCC, no. CRL-1573). This cell line was stably transfected with the Epstein Barr 
virus (EBV) nuclear antigen 1 (EBNA-1) gene. These cells propagate plasmids 
containing an EBV replication origin and keep it episomal (Young et al., 1988). The 
expression of the EBNA-1 gene is controlled by a CMV promoter and combined with a 
neomycin resistence gene (Lambert et al., 1988). Therefore, the cell line has to be 
cultured permanently with geneticin (G418), a neomycin analogon.  
 
DMEM F-12, Gibco BRL, UK 
10 % (v/v) FCS, Invitrogen, UK 
1 % (v/v) penicillin-streptomycin, PAA, Germany 
175 µg/ml geneticin (G418), PAA, Germany 
 
Table 4-18: HEK 293 EBNA growth medium (EBNA-GM) 
 
4.5.5.2.2.4. HEK 293 EBNA Strep 16 cells 
These cells were derived from the HEK 293 EBNA cell line transfected with the 
expression vector pCEP Pu BM40SP C-StrepII to stably express recombinant collagen 
XVI. 
Growth medium for transfected cells was EBNA-GM supplemented with 0.5 µg/ml 
puromycin (Biomol, Germany).  
 
4.5.6. Proliferation assay 
96-well plates (Falcon, USA) were coated with poly-L-lysine (5 µg/ml, Sigma, USA), 
collagen I (10 µg/ml, Sigma, USA) and recombinant collagen XVI (Kassner et al., 
2004) (10 µg/ml and 30 µg/ml) over night at 4 °C. Unspecific binding sites were 
blocked with 1 % (w/v) BSA (Biomol, Germany) solution for 2 hrs at rt. The plates 
were washed two times with PBS and stored at 4 °C until usage. Cells were trypsinized 
and cultivated over night at 37 °C and   5 % CO2 at a density of  7,500 cells/well.  EZ4U 
(Biomedica, Austria) proliferation assay was performed according to the manufacturer’s 
protocol for 2 hrs. In this assay tetrazolium is reduced to formazan by active succinat 
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dehdrogenase of living cells. This reduction process requires functional mitochondria 
which are inactivated within a few minutes after cell death. Absorption was determined 
at 450 nm and a reference wavelength of 600 nm.  
 
4.5.7. Adhesion assay 
96-well plates were coated as described above and ISEMF were seeded at a density of 
7,500 cells/well into the plates. Cells were allowed to adhere for 30 min and 60 min at 
37 °C at 5 % CO2. Subsequently, plates were washed with PBS in order to remove non-
adhered cells. Adhered cells were fixed with 1 % (v/v) glutaraldehyde solution (Merck, 
Germany) for 30 min. Glutaraldehyde was removed and cells were washed with PBS 
again. Fixed cells were stained with 0.02 % (w/v) crystal-violet solution (Sigma, 
Germany) for 15 min at rt and washed with tap water. Bound crystal violet was 
removed by incubation for 3 hrs at a horizontal shaker at 100 rpm with 70 % (v/v) 
ethanol (Roth, Germany). Crystal violet adsorption was measured at 600 nm and each 
sample was performed in triplicates.  
 
4.5.8. Migration assay 
ISEMF were seeded at a density of 20,000 cells/well into a 24-well plate and grown to 
confluency at 37 °C and 5 % CO2. Confluent cell layers were scratched with a 100 µl 
pipet tip and cells were supplied with fresh cell culture medium. The width of the 
scratch was determined after 0 hrs, 2 hrs, 6 hrs and 24 hrs and related to the covered 
surface. Completely covered cell culture surface referred to 100 % whereas the wound 
at 0 hrs referred to 0 %.  
 
4.5.9. Live/dead assay 
Living cells can be distinguished from dead cells by the presence of intracellular 
esterase activity which was determined by the enzymatic conversion of cell-permanent 
calcein acetoxymethylester (calcein AM) to the fluorescent calcein. This dye is retained 
in living cells and can be detected by fluorescent emission (ex/em ~495 nm/~515 nm). 
Ethidium homodimer (EthD-1) enters only cells with a defect membrane. Fluorescence 
is enhanced upon binding to nucleic acids, producing a bright red fluorescence in dead 
cells (ex/em ~495 nm/~635 nm). This dye is excluded by the intact plasma membrane 
of living cells. 
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Cells were cultured subconfluently in 96-well plates and washed with PBS to remove 
medium residues. 0.025 % (v/v) calcein and 0.05 % (v/v) EthD-1 (both Molecular 
Probes, Germany) were solubilized in PBS. Per well, 300 µl of this mixture were added 
and incubated in the dark at 37 °C and 5 % CO2. After 45 min the solution was removed 
and the cells were washed with PBS. The substrate toxicity was determined by the ratio 
of dead to living cells.  
 
4.6. Preparation of recombinant collagen XVI in HEK 293 EBNA cells 
4.6.1. Episomal expression system of collagen XVI in HEK 293 EBNA cells in 
roller flask culture 
To obtain high amounts of recombinant collagen XVI plastic roller flasks with an inner 
surface of 2125 cm² were used to culture HEK 293 EBNA Strep 16 cells. The cells were 
originally passaged from 75 cm² flasks in a ratio of 1:5 into 175 cm² flasks. After 
reaching confluence, cells obtained from two flasks were transferred to one roller flask 
containing 100 ml of culture medium. Defined gas exchange was guaranteed under 
sterile conditions with 5 % CO2 and roller flasks were tightly closed and incubated at  
37 °C in a temperature controlled rolling incubator (0.5 - 0.7 rpm). Serumfree medium 
for generation of conditioned medium was supplemented with 175 µg/ml geniticin 
(PAA, Germany). 
 
DMEM F-12 (Dulbecco’s modified eagle’s medium), Gibco BRL, UK 
256 µM ascorbic acid, Sigma, USA 
1 mM ascorbate-2-phosphate, Sigma, USA 
1 mM sodium pyruvate, Sigma, USA 
1 mM cystein, Sigma, USA 
1 % (v/v) penicillin-streptomycin, PAA, Germany 
 
Table 4-19: Serum-free medium (SFM) 
 
4.6.2. Generation of recombinant collagen XVI containing conditioned medium 
HEK 293 EBNA Strep 16 cells were cultured in serum containing medium for 48 - 54 
hrs and finally the medium was replaced by 50 ml serum-free medium (SFM) per flask. 
The conditioned medium was collected and centrifuged (10 min at room temperature, 
3540 x g) after 48 hrs and replaced with fresh medium. The supernatant was mixed with 
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avidin (Merck, Germany) in a final concentration of 833 µg/l and kept at 4 °C until it 
was applied to affinity chromatography for protein purification. The generation of 
conditioned medium was repeated up to six times with the same cells.    
 
4.6.3. Purification of recombinant collagen XVI 
Recombinantly produced collagen XVI was purified employing an oligo peptide, the C-
terminal StrepII-Tag (comprising of the sequence WSHPQFEK) with a high affinity to 
Strep-Tactin that way allowing affinity purification of the protein. 
 
4.6.4. Affinity chromatography with Strep-Tactin columns 
Fusion proteins containing a StrepII-Tag bind tightly to a modified streptavidin called 
Strep-Tactin (Skerra and Schmidt, 2000) immobilized on an affinity column. The 
elution of the bound protein is enabled by competition to desthiobiotin that binds 
reversibly to the column matrix. Columns are regenerated by exchanging desthiobiotin 
with the azo dye HABA (2-(4-hydroxyphenylazo)benzoe-acid). Recombinant collagen 
XVI was purified according to the manufacturer’s protocol (IBA, Germany). The 
elution of the protein was performed with pre-chilled buffers and the following dialysis 
against sterile PBS was performed at 4 °C.  
The collagen XVI conditioned medium was mixed with avidin (833 µg/ml) to form an 
avidin-biotin complex and cooled down to 4 °C. Before medium was loaded on to the 
affinity column, the initial volume was mixed with 0.1 volumes of buffer W (10x). The 
prepared medium passed the pre-equilibrated (100 ml buffer W) column, just with 
gravity force. Afterwards, the column was washed with 50 ml buffer W prior to elution 
with 25 ml buffer E which was monitored by an UV detector (Uvicord SII, Amersham 
Biosciences) with a one channel recorder (R111, Amersham Biosciences). The eluted 
protein was fractionated into 1.5 to 2 ml aliquots. Fractions were pooled according to 
the protein content and dialysed against sterile PBS. Protein concentration was 
determined using the BCA assay and approved by immunoblotting.  
Regeneration of the column material was performed with 50 ml buffer W, followed by 
100 ml buffer R. The matrix was prepared for repeated chromatography by washing 
with 100 ml buffer W. All buffer components and concentrations are listed in table 4-
20.  
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Buffer  Components 
Buffer W 100 mM Tris, 150 mM NaCl, 1 mM EDTA, pH 8.0, all 
AppliChem, Germany 
Buffer W (10x) 1 M Tris, 1.5 M NaCl, 10 mM EDTA, pH 8.0, all AppliChem 
Germany 
Buffer E Buffer W + 2.5 mM desthiobiotin, Sigma, USA 
Buffer R Buffer W + 1 mM HABA (Fluka, Germany) 
 
Table 4-20: Buffer concentrations for affinity chromatography utilizing Strep-Tactin 
columns 
 
4.7. Statistical analysis 
Results are shown in average values ± standard error of mean. In experiments with 
ISMEF, for each inflammation stage at least 4 patients were analyzed in triplicates. A 
detailed patient list and related experiments is found in table 4-13. In gene silencing 
experiments significances are calculated for three independent knockdown cell batches. 
Significances were determined with assistance of GraphPadPrism v.5 by one-way 
Anova analysis of variance with Tukey’s multiple comparison test for the proliferation 
and student’s t-test for adhesion assays and integrin expression profile. In gene silencing 
and downstream experiments one-way Anova analysis of variance with Tukey’s 
multiple comparison test was applied.  
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5. Results 
 
What we think, or what we know, or what we believe is, in the end, of little consequence. 
The only consequence is what we do. – John Ruskin 
 
Part I: The role of collagen XVI in pathological disorders 
 
5.1. Recombinant expression of collagen XVI in HEK 293 EBNA cells 
The expression system of collagen XVI in HEK 293 EBNA cells has been established 
previously (Kassner et al., 2004). However, due to passaging, the transfected cells had 
gradually lost their potential to efficiently express collagen XVI. Therefore, new cell 
batches were transfected with pCEP Pu vector encoding for the alpha1 chain of collagen 
XVI.  
 
5.1.1. Purification of recombinant collagen XVI  
Transfected cells secrete collagen XVI which can be purified with affinity 
chromatography based on a Strep-Tactin–StrepII-Tag binding to the C-terminal StrepII-
Tag. Immunoblotting with an antibody against collagen XVI in figure 5-1 shows protein 
fragments of 213 kDa, 182 kDa, 133 kDa and 78 kDa whereas immunoblotting with an 
antibody against the StrepII-Tag does not display the 133 kDa fragment.  
 
Figure 5-1: Immunoblots of serum-free 
conditioned medium from transfected HEK 293 
EBNA cells using antibodies against collagen XVI 
(A) and StrepII-Tag (B). 
100 µl serum-free medium, conditioned for 48 hrs 
on a 75 cm² cell culture flask was applied. 
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Recombinantly produced collagen XVI was isolated from at least 400 ml conditioned 
medium of roller cultures. Affinity purification was performed on a 10 ml Strep-Tactin 
Superflow column. 5 to 10 ml of protein solution with 90 to 150 µg/ml protein was 
obtained per purification cycle which refers to an average total protein amount of 3.0 
mg collagen XVI per liter conditioned medium.  
 
 
Figure 5-2: Standard elution profile obtained from 
affinity purification of recombinant collagen XVI 
using a Strep-Tactin column of 10 ml volume.  Elution 
was performed with 50 ml elution buffer containing 
2.5 mM desthiobiotin. 1.5 ml fractions were collected. 
The peak fractions (#6 to #12) were pooled and 
dialyzed. One elution resulted in 600 µg to 1200 µg 
recombinant collagen XVI. The elution profile was 
recorded with a detector sensitivity of 0.1 V. 
 
 
 
 
 
5.1.2. Long-term storage of recombinant collagen XVI 
The storage of recombinant collagen XVI was performed as a 50 % glycerol stock 
solution at -80 °C after shock freezing in liquid nitrogen or as lyophilized protein at       
-80 °C. Collagen XVI stored at 4 °C adheres to vessel surfaces and gradually degrades. 
Freezing at -20 °C destroys the collagen helix by crystallized ice layers formed during 
concentration dependent gradient freezing at this temperature.  
 
5.2. Molecular distribution of collagen XVI in the human intestinal wall 
Collagen XVI is a component of the extracellular matrix produced by keratinocytes and 
fibroblasts in skin (Grassel et al., 1999). Here, we focused on immunofluorescence 
staining of bowel tissue derived from Crohn’s disease patients. We compared 
histological normal appearing tissue with diseased tissue represented by strictured areas. 
Immunofluorescence staining of intestinal sections with anti-α-smooth muscle actin and 
anti-collagen XVI antibodies revealed collagen XVI distribution throughout all bowel 
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layers. Collagen XVI is localized in the epithelial cell layer and matrix of the luminal 
surface and is produced by cells throughout the intestinal mucosa. In addition, 
mesenchymal cells of the lamina propria (Fig. 5-3 A, B, white arrow heads) and 
underlying muscular layers, here predominantly around blood vessels, stain positive for 
collagen XVI (Fig. 5-3 C, and D, white arrow heads). Collagen XVI is equally 
distributed on sections from CD patients within areas where the normal composition of 
bowel layers is still retained (Fig. 5-3 E, H). Strictures, a characteristic of the disease, 
lack distinct compartments and are comprised of the different intestinal tissues in 
varying composition. In these strictured parts (Fig. 5-3 F, G) collagen XVI positive cells 
appear more densely packed in the submucosa compared to healthy sections (Fig. 5-3 
C). Collagen XVI seems closely restricted to single cells, however in strictures collagen 
XVI is deposited into the ECM and is found around cells (Fig. 5-3 E, F). 
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Figure 5-3: Morphological distribution of collagen XVI in healthy and CD tissue 
sections. 
Morphological distribution of collagen XVI (green fluorescence) and α-smooth muscle 
actin (red fluorescence) in paraffin sections is depicted for the bowel wall of healthy 
tissue (A-D) versus CD tissue (E-H). Arrow heads indicate representative positive 
staining for collagen XVI. Bar represents 100 µm. 
c: crypts, m: muscle layer, s: submucosa, bv: blood vessel, e: erythrocytes, ep: epithelial 
cells, lp: lamina propria   
 
5.3. Distribution of α1- and α2 integrin in the human colon 
Immunofluorescence staining of α1 integrin in the human colon revealed a co-
localization with collagen XVI in the lamina propria, whereas α2 integrin is mainly 
expressed by epithelial cells of the crypts. 
 
Figure 5-4: Morphological distribution of Collagen XVI and α1 integrin in colon tissue 
sections (cryo sections). Bar represents 100 µm.  
Morphological distribution of collagen XVI (red fluorescence, A) and α1 integrin (green 
fluorescence, B) is depicted for the bowel wall. Collagen XVI and α1 integrin are 
colocalized (merge, C). 
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Figure 5-5: Morphological distribution of Collagen XVI and the integrin α2 in colon 
tissue sections (cryo sections). Bar represents 100 µm.  
Morphological distribution of collagen XVI (red fluorescence, A) and α2 integrin (green 
fluorescence, B) is depicted for the bowel wall. Merge is depicted in C. 
 
5.4. Intestinal subepithelial myofibroblasts (ISEMF) express  collagen XVI 
5.4.1. Gene expression analysis of collagen XVI in ISEMF and intestinal 
epithelial cells 
ISEMF from each inflammation stage and intestinal epithelial cells showed collagen 
XVI gene expression in qualitative PCR (data not shown) as already demonstrated in 
immunohistochemistry in 5.2. Collagen XVI could also be detected in intestinal 
epithelial cells from healthy patient material. 
 
5.4.2. Immunocytochemical analysis of ISEMF 
ISEMF of all inflammation stages synthesized collagen XVI protein that was located all 
over the cellular body (Fig. 5-6). A matrix deposition of collagen XVI could not be 
detected during the cultivation period of 24 hrs. Co-staining with fibronectin revealed 
the same distribution in the cell with a higher concentration around the nuclei and no 
matrix deposition. ISEMF exhibit similar morphology irrespective of inflammation 
degree. 
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Figure 5-6: Immunocytochemical staining for collagen XVI (green). 
Large pictures depict only collagen XVI protein, whereas inlets show merge of collagen 
XVI and fibronectin (yellow). All inflammation stages are shown in one representative 
image: non-inflamed (A), slightly inflamed (B), moderately inflamed (C) and highly 
inflamed (D). 
 
5.4.3. Immunoblotting of  ISEMF cell lysates (Western blotting) 
Collagen XVI protein production was analyzed with immunoblotting of cell lysates. 
Increased levels of collagen XVI were found in moderately and highly inflamed cells 
compared to lower inflammation stages (Fig. 5-7 C). The CCD18Co cells synthesized 
clearly more collagen XVI as ISEMF from non- or slightly inflamed tissue biopsies. We 
detected proteolytically cleaved fragments of collagen XVI as reported for smooth 
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muscle cells and dermal fibroblasts (Grassel et al., 1996). Most prominently present was 
the ~ 180 kDa fragment besides the ~ 220 kDa, ~ 130 kDa and ~ 78 kDa fragments. 
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Figure 5-7: Immunoblotting of cell lysates for collagen XVI and ß-actin. 
Immunoblotting of collagen XVI was performed with 20 µg RIPA protein lysates of 
ISEMF per lane after 24 hours culture in serum-free medium. For each inflammation 
stage one representative image is depicted. Bands between 75 kDa and 250 kDa 
represent collagen XVI (full length protein ~ 220 kDa); bands below 50 kDa represent 
ß-actin employed as loading control. For each inflammation stage cells from at least 
four patients have been investigated 
 
5.4.4. Integrin expression profile of intestinal subepithelial myofibroblasts 
Integrin expression profile of ISEMF was determined for the α1- and α2 integrin 
subunits (Fig. 5-8). Expression profiles of β1, α10 and α11 intergrin subunits have been 
investigated additionally, but revealed no significant changes on the myofibroblasts 
with respect to inflammation stage (data not shown). α1 integrin surface expression was 
very weak on non-inflamed (Fig. 5-8 B) and slightly-inflamed ISEMF (Fig. 5-8 C). 
However, increasing inflammation severity was significantly associated with increasing 
α1 integrin expression on the cell surface of ISEMF (Fig. 5-8 D, E) while α2 integrin 
expression remained unchanged in all stages of inflammation. Compared to the isotype 
control the CCD18Co cell line showed a clear increase of α1 integrin surface expression 
compared to α2 integrin (Fig. 5-8 A). 
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Figure 5-8: Cell surface expression of α1- and α2 integrin subunits on ISEMF and 
CCD18Co cells was determined using flow cytometry. Geometric mean (g-mean) of the 
fluorescence intensity was determined using WinMDI 2.8 software and shows integrin 
expression rates for the CCD18Co cell line (A), non-inflamed ISEMF (B), slightly 
inflamed ISEMF (C), moderately inflamed ISEMF (D) and highly inflamed ISEMF (E) 
always compared to the negative isotype control. The panel below shows a 
representative FACS histogram of one patient. n = 5 (non-inflamed), n = 4 (slightly 
inflamed), n = 4 (moderately inflamed), n = 4 (highly inflamed) 
* p<0.05  
 
5.4.5. Effect of recombinant collagen XVI on the metabolism of intestinal 
subepithelial myofibroblasts 
5.4.5.1. Effect of recombinant collagen XVI on cell viability 
Collagen XVI was applied in concentrations of 10 µg/ml and 30 µg/ml to tissue culture 
surfaces. Collagen XVI effect on cell viability was determined after over night culture 
of cells in a live/dead assay. Membrane-permeant calcein was cleaved by esterases in 
living cells which resulted in green fluorescence. The membrane-impermeant ethidium 
homodimer labeled nucleic acids of membrane-compromised cells and showed red 
fluorescence. With this assay no cytotoxic effect of collagen XVI in ISEMF could be 
detected.  
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Figure 5-9: Live/dead assay on ISEMF. CCD18Co cells, non-inflamed and highly 
inflamed cells were stained with calcein (green fluorescence) for living cells and 
ethidium homodimer-1 (red fluorescence) for dead cells. 
 
5.4.5.2. Effect of collagen XVI on adhesion properties of ISEMF  
Overall, ISEMF revealed a reduced adhesion capacity if derived from non-, slightly- 
and moderately inflamed tissue biopsies on all coatings compared to the CCD18Co cell 
line (Fig. 5-10 A-F). The CCD18Co cell line and non-inflamed ISEMF showed 
profoundly reduced adhesion capacities on collagen XVI compared to poly-L-lysine 
(PLL) and collagen I (Fig. 5-10 A, B). A comparable adhesion spectrum could be 
observed for moderately inflamed ISEMF, however without reaching significance (Fig. 
5-10 D). Slightly inflamed cells adhere the weakest with no difference regarding the 
substrates. With increasing inflammation adhesion capacity on collagen XVI was 
unchanged with respect to PLL, collagens I and XVI (Fig. 5-10 C, D, E) however, there 
is a  tendency towards less adhesion on collagen XVI (Fig. 5-10 D, E). Figure 5-10 A-D 
displays cellular adhesion spectra to different substrates and figure 5-10 F compares cell 
adherance tendency of different inflammtion stages to collagen I and collagen XVI 
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substrates. ISEMF obtained from moderately and highly inflamed tissue adhered 
stronger on collagen XVI as non-inflamed or slightly inflamed cells did (Fig. 5-10 F). 
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Figure 5-10:  Adhesion properties of ISEMF 
Adhesion was determined by crystal violet staining of CCD18Co (A) and ISEMF 
isolated from increasingly inflamed CD tissue biopsies (B-E) left to adhere on coated 96 
well plates for 30 min. Adhesion was determined for differently inflamed ISEMF on 
following coatings: 10 mg/ml BSA; 5 µg/ml poly-L-lysine (PLL); 10 µg/ml collagen I 
(Col I); 10 µg/ml collagen XVI (Col XVI 10); 30 µg/ml collagen XVI (Col XVI 30). A-
E display adhesion spectra of cells from one inflammation stage on different substrates 
and F displays adhesion tendency of cells from different inflammation stages on 
collagen I and collagen XVI. n = 5 for each inflammation stage 
* p<0.05; ** p<0.01; *** p<0.001 
 
5.4.5.3. Effect of collagen XVI on cell spreading of ISEMF 
A more pronounced cell spreading on collagen XVI compared to collagen I could be 
observed for ISEMF from all inflammation stages with scanning electron microscopy 
(Fig. 5-11). 
 
 
Figure 5-11: Cell spreading of ISEMF 
ISEMF and CCD18Co cells were cultured with a density of 10,000 cells/ml on coated 
glass slides for 3 hrs and cell spreading and cell shape were optically evaluated by 
scanning electron microscopy. Cell spreading was promoted on poly-L-lysine and 
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collagen XVI compared to collagen I and the BSA. Representative images were 
depicted (n = 3). 
 
5.4.5.4. Effect of collagen XVI on cell number of ISEMF 
Figure 5-12 displays data obtained by assaying proliferation of CCD18Co cells (Fig. 5-
12 A) and  ISEMF (Fig. 5-12 B) in all inflammation stages. Proliferation assay was 
performed analyzing total cell number seeded on 1 % (w/v) BSA, poly-L-lysine (5 
µg/ml), collagen I (10 µg/ml), and two different concentrations of collagen XVI (10 
µg/ml and 30 µg/ml). As ISEMF obtained from different inflammation stages did not 
display changes in their total cell number on all tested culture substrates, data for all 
inflammation stages were combined (Fig. 12 B). Cell line CCD18Co showed increased 
proliferation on both collagen XVI coating concentrations compared to collagen I and 
poly-L-lysine and thus presumably an increased proliferative rate. 
Figure 5-12: Total cell number of ISEMF. 
Proliferation assay (EZ4U) was performed with ISEMF in different inflammation stages 
grown overnight on coated well plates. The cell line CCD18Co exhibited the highest 
total cell number on collagen XVI as substrate (A), while proliferation capacity of 
ISEMF from different inflammation stages remained unchanged. Data from these 
experiments were combined (B). 
n = 5 (A); n = 14 (B); *** p<0.001 
 
5.4.5.5. Effect of collagen XVI on the migratory behaviour of ISEMF 
The migration assay revealed no differences in migration properties according to 
inflammation stages nor according to culture substrates (data not shown).  
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5.4.5.6. Effect on the formation of focal adhesion contacts – 
determination of quantity and maturation stage 
Collagen XVI and collagen I promoted formation of vinculin containing focal adhesion 
contacts on ISEMF from all inflammation stages compared to poly-L-lysine and the 
BSA control (Fig. 5-13, 5-14) with the strongest focal adhesion contact formation on 
recombinant collagen XVI as substrate (Fig. 5-13 A-E). In general, higher counts of 
focal adhesion contacts refer to better cell spreading as demonstrated in figure 5-11. 
Overall, non-inflamed cells and cells from the early inflammatory phase showed 
elevated numbers of total focal adhesion contacts compared to moderately or highly 
inflamed ISEMF (Fig.5-13 A-E), as summarized for collagens I and XVI as substrates 
(Fig. 5-13 F). Figure 5-13 A-D displays focal adhesion formation spectra on different 
substrates and figure 5-13 F compares focal adhesion formation tendency on collagen I 
and collagen XVI substrates.  
In addition, the length of vinculin containing focal adhesion contacts revealed a similar 
tendency as their amount (Fig. 5-15 A-F). Collagen I and collagen XVI induce 
maturation and, therefore length of focal adhesion contacts in all inflammation stages 
compared to poly-L-lysine. In ISEMF derived from all inflammation stages collagen 
XVI even appeared to promote formation of much significantly longer focal adhesion 
contacts compared to collagen I (Fig. 5-15 C-E). However, total length of focal 
adhesions decreased in inflamed ISEMF compared to non-inflamed on collagens I and 
XVI (Fig. 5-15 F). Figure 5-15 A-D displays focal adhesions length spectra on different 
substrates and figure 5-15 F compares focal adhesions lenght tendency on collagen I 
and collagen XVI substrates. 
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Figure 5-13: Formation of focal adhesion contacts – quantitation 
CCD18Co cells and ISEMF were cultured over night on coated glass slides and stained 
with ALEXA fluorophores for actin stress fibers (phalloidin coupled antibody) and the 
presence of focal adhesion contacts (anti–vinculin antibody). Focal adhesion contacts 
were counted per cell sample and per inflammation stage in five independent fields of 
  Results 
 - 72 -
view and referred to as focal adhesion contacts per cell.  A-E display spectra of the 
amount of focal adhesions on different substrates and F displays the tendency of amount 
of focal adhesion contacts on collagens I and XVI during increasing inflammation. n = 5 
(non-inflamed), n = 4 (slightly inflamed), n = 4 (moderately inflamed), n = 3 (highly 
inflamed) 
*p<0.05; ** p<0.01; *** p<0.001 
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Figure 5-14: Formation of focal contacts – immunofluorescence 
Fluorescence stainings for vinculin (green fluorescence) and actin stress fibres (red 
fluorescence) are depicted for non- (A) and highly inflamed cells (B). Representative 
images of one patient per inflammation stage are depicted. n = 3 (non inflamed), n = 3 
(highly inflamed) 
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Figure 5-15: Maturation of focal adhesion contacts 
CCD18Co cells and ISEMF were cultured over night on coated glass slides and stained 
with ALEXA fluorophores for actin stress fibers (phalloidin coupled antibody) and the 
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presence of focal adhesion contacts by an anti-vinculin antibody. The length of focal 
adhesion contacts was evaluated for ISEMF and referred to as the average length. A-E 
display spectra of focal adhesions length from cells of one inflammation stage on 
different substrates and F displays tendency of focal adhesion contacts length on 
collagens I and XVI of the different inflammation stages. n = 5 (non-inflamed), n = 4 
(slightly inflamed), n = 4 (moderately inflamed), n = 3 (highly inflamed) 
* p<0.05; ** p<0.01; *** p<0.001 
 
5.4.5.7. Recruitment of α1 integrin into focal adhesion contacts 
Double immunofluorescence staining for α1 integrin (red fluorescence) and vinculin 
(green fluorescence) was compared for all inflammation stages on BSA control, poly-L-
lysine, collagen I and collagen XVI. Non-inflamed and highly inflamed cells are 
depicted in figure 5-16 A and B, respectively. The increased cell spreading on 
recombinant collagen XVI, demonstrated in scanning electron microscopy in figure 5-
11, was confirmed by immunofluorescence staining. On collagen I and collagen XVI, 
these cells recruited α1 integrin into the focal adhesion contacts. ISEMF on poly-L-
lysine, used as control showed focal adhesion contacts, however α1 integrin staining 
was very weak and remained unchanged in the presence of 0.1 mM MnCl2. Focal 
adhesion contacts of ISEMF on collagen XVI were not only increased in number like on 
collagen I but also showed a wider distribution all over the cellular body. On collagen I, 
focal adhesion contacts were mainly restricted to the cellular periphery. Highly 
inflamed ISEMF showed increased staining intensity of α1 integrin on collagen I and 
collagen XVI coatings. Increased staining was also evident in the presence of 0.1 mM 
MnCl2, which indicates an additional activation of α1 integrin. 
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Figure 5-16:  Distribution of α1 integrin on the cell surface of ISEMF 
ISEMF of different inflammation stages (A: non inflamed, B: highly inflamed) were 
seeded on coated glass cover plates in the presence and absence of 0.1 mM MnCl2 on 
poly-L-lysine (PLL), collagen I (Col I) and collagen XVI (Col XVI). After 6 hrs cells 
were fixed and double-stained with a rabbit antibody against vinculin and a murine 
antibody against α1 integrin. With laser scanning microscopy α1 integrin (red 
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fluorescence, middle row) and vinculin (green fluorescence, left row) were visualized 
with 400 x magnification. Colocalization is depicted in the right row (merge) and 
appears in yellow color. Bar represents 100 µm. 
 
Part II: Establishement of a retroviral mediated gene silencing model 
 
5.5. Retroviral mediated gene silencing of collagen XVI  
5.5.1. Generation of virus particles 
The replication incompetent shRNA was stably integrated into the ecotropic EcoPack-
293 packaging cell line genome. Infectious retroviral particles containing the shRNA 
were produced and utilized to infect the murine fibroblast cell line NIH3T3. Puromycin 
restistance enabled selection and enrichment of positive cell clones which had 
incorporated the plasmid. A MluI cleavage site located within the shRNA sequence was 
used as insertion control of the shRNA (data not shown). Positive cell clones were 
sequenced to determine correct DNA alignment and shRNA sequence (Fig. 5-17). 
BamH I Mlu I
EcoR I  
Figure 5-17: Sequence analysis of one shRNA clone (shColXVI1a) showing correct 
alignment with the plasmid construct. Black lines show restriction overhangs for 
BamHI, EcoRI and MluI integrated in the shColXVI sequence (red line). Sequence 
outside the marked area represents vector sequence. Further knockdown experiments 
refer to this shRNA clone.  
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5.5.2. Controlling gene and protein expression of collagen XVI in NIH3T3 cells 
after knockdown 
Transduction efficiency was evaluated seven days after transduction and antibiotic 
selection. Gene expression level was determined as absolute cDNA copy numbers using 
a plasmid standard curve (Fig. 5-18 A). GAPDH gene expression served as control and 
remained unaffected (data not shown). A knockdown of ~90 % was observed in 
comparison to the control cells which were transduced with viral particles containing an 
unrelated luciferase shRNA.  
The knockdown was also evaluated on protein level with immunoblotting. An absence 
of around 100 % could be observed for the full-length collagen XVI chain. 
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Figure 5-18: Analysis of knockdown efficiency of Col16a1 was performed at mRNA 
level with quantitative PCR and shows 91 % lower Col16a1 gene expression in 
transduced cells compared to control cells transduced with luciferase shRNA (A). 
Almost 100 % knockdown was achieved regarding the full-length collagen XVI protein 
(B, lane 2). ß-actin expression is unaffected which indicates a specific knockdown of 
collagen XVI. n = 3 
 
5.5.3. Downstream processing of transduced NIH 3T3 
Collagen XVI knockdown downstream effects of other expressed proteins were 
analyzed by 2D-gelelectrophoresis. These results were completed by relative gene 
expression analysis of these candidate genes. Collagen XVI is actively linked via 
integrins with the cytoskeleton and a previously performed knockdown of collagen XVI 
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in human glioma cell lines resulted in a change of actin-related genes (Senner et al., 
2008).  
 
5.5.3.1. Identification of differentially expressed proteins by 2D-
gelelectrophoresis 
For 2D-gelelectrophoresis whole cell lysates of knockdown cells were applied onto 
separate gels and visualized with Coomassie Blue staining. From all differentially 
screened spots the two most prominent ones were identified by mass spectrometry. This 
analysis revealed that peptidyl-prolyl-isomerase A (Fig. 5-19, 1) and macrophage 
migration inhibitory factor (Fig. 5-19, 2) were absent in collagen XVI knockdown cells.  
A B
1
2
1
2
 
Figure 5-19: Control NIH3T3 cells (A) and crude cell lysates from collagen XVI 
knockdown (B) were applied on separate gels for 2D-gelelectrophoresis. Among several 
differentially expressed protein spots two were isolated and further analyzed with 
MALDI-TOF. Sequence analysis revealed peptidyl-prolyl-isomerase A, PPIA (1) and 
macrophage migration inhibitory factor, MIF (2) to be absent in knockdown (B).  n = 3  
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5.5.3.2. Gene and protein expression of MIF and PPIA 
Expression of MIF and PPIA was altered in knockdown cells compared to control cells 
on protein level in 2D-gelelectrophoresis. Gene expression however, revealed a slight 
up-regulation of both genes determined in relative quantitative PCR.   
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Figure 5-20: Gene expression of MIF and PPIA was investigated with relative 
quantification (∆∆Ct method) in relation to 18sRNA. Three independent knockdown 
experiments resulting in a knockdown of 70-90 % showed a slight upregulation of PPIA 
and MIF.  
* p<0.05 
 
The protein expression of MIF and PPIA was determined by immunoblotting of 10 µg 
RIPA cell lysate. Protein expression was clearly down-regulated in cells lacking 
collagen XVI (Fig. 5-21).  
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Figure 5-21: Western blot analysis of 10 µg crude cell lysate (RIPA) confirmed results 
obtained with 2D-gelelectrophoresis. Here, PPIA and MIF showed a lower expression 
on protein level. ß-actin served as loading control. n = 3 
 
5.5.3.3. Functional analysis of collagen XVI silenced NIH3T3 
5.5.3.3.1. Adhesion capacity  
Adhesion of control and knockdown cells was determined after 30 min (Fig. 5-22 A), 
90 min (Fig. 5-22 B), and 18 hrs (Fig. 5-22 C) on several coatings (1 g/ml BSA; PLL: 5 
µg/ml poly-L-lysine; Col I: 10 µg/ml collagen I; Col XVI 10: 10 µg/ml collagen XVI; 
Col XVI 30: 30 µg/ml collagen XVI). After 30/90 min, profound increased adhesion 
was observed for luciferase control compared to knockdown cell. After 90 min, 
adhesion differences due to the coating material are no longer evident. On all coatings a 
reduced adhesive capacity was observed for NIH3T3 cells with a collagen XVI 
knockdown. After 18 hrs no adhesion differences were detected.  
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Figure 5-22: Adhesion assay on different coating substrates with collagen XVI silenced 
NIH3T3 cells compared to the luciferase control.  
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The adhesion assay was performed with three independent knockdown cell batches 
ranging from 70 % – 90 % collagen XVI knockdown. * p<0.05; ** p<0.01 
 
5.5.3.3.2. Proliferation properties 
Figure 5-23 displays data obtained from assaying proliferation (EZ4U) of luciferase 
transfected and collagen XVI knockdown cells. Proliferation assay was performed using 
1 % (w/v) BSA, poly-L-lysine (5 µg/ml), collagen I (10 µg/ml), and two different 
concentrations of collagen XVI (10 µg/ml and 30 µg/ml). Cells did not show differences 
in total cell number with respect to the culture substrates, however, NIH3T3 with 
reduced collagen XVI expression had lower cell numbers and thus were presumably 
restricted in their proliferation capacity on all coatings. 
BS
A
PL
L
Co
l I
Co
l X
VI
 10
Co
l X
VI
 30 BS
A
PL
L
Co
l I
Co
l X
VI
 10
Co
l X
VI
 30
0
1
2
LUC control Col XVI knockdown
***
ab
so
rp
tio
n
 
Figure 5-23: Proliferation properties of collagen XVI knockdown cells and luciferase 
control. 
Proliferation assay (EZ4U) was performed with collagen XVI knockdown cells and 
NIH3T3 transfected with the luciferase control seeded on coated well plates. Data of 
three independent knockdown experiments were combined.  *** p<0.001 
 
5.5.3.3.3. Migratory behaviour 
Scratch assay of collagen XVI knockdown cells and luciferase control cells on tissue 
culture surface revealed no differences in migration (data not shown).  
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6. Discussion 
 
"It is better to know some of the questions than all of the answers." James Thurber 
 
Part I: The role of collagen XVI in pathological disorders 
 
6.1. Recombinant expression of collagen XVI 
Collagen XVI is a minor component of specialized tissues like skin or cartilage and 
therefore, it is difficult to isolate larger amounts of the authentic protein from tissue 
samples. Isolation methods that are usually applied for fibrillar collagens are not 
suitable for FACIT collagens like collagen XVI (Deyl and Miksik, 2000). Pepsin 
digestion performed in this method destroys non-collagenous proteins and non-
collagenous domains thus leaving a fragmented collagen XVI (Grassel et al., 1996). 
Formerly established protocols for recombinant collagen XVI production in a HEK 293 
EBNA expression system have been successfully applied in this work (Kassner et al., 
2004). The HEK 293 EBNA cell line expresses the Epstein-Barr-Virus (EBV) Nuclear 
Antigen 1 (EBNA1). Therefore, the cells are enabled to keep plasmids containing a 
resistence gene in addition to an EBV-replication origin stably integrated episomal. The 
utilized pCEP Pu vector contains a BM40 signal peptide for increased secretion of 
proteins and a C-terminal StrepII-Tag which allows affinity purification of non-
denatured recombinant protein. 
Expression rates of collagen XVI were increased from documented 1.5 mg up to 3.0 mg 
recombinant protein per liter conditioned medium purified by affinity chromatography 
with a Strep-Tactin-Superflow column. Culture of collagen XVI expressing HEK 293 
EBNA cells in plastic roller flasks instead of glass roller flasks allowed longer 
cultivation duration, an up-scale in culture surface from 100 % up to 240 %, and thus a 
doubling in protein yield.  
The molecular weight of recombinant collagen XVI was determined by 
electrophoretical mobility (Kassner et al., 2004). The full-length alpha1 chain (213 kDa) 
plus proteolytically cleaved fragments were identified: a 182 kDa polypeptide lacking 
the NC11 domain, a 78 kDa fragment containing two C-terminal collagenous domains 
(COL1 and COL2), and finally a 133 kDa polypeptide, presumably lacking C-terminal 
domains. All of these processed proteins were detected after affinity purification.  
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6.2. Collagen XVI in Crohn’s disease 
6.2.1. Molecular  distribution and cellular expression of collagen XVI  
During the course of Crohn’s disease the composition of the intestinal ECM has an 
immense impact on the behaviour of therein occurring cells and progression of the 
disease. Data on excessive collagen matrix production in CD patients has been either 
focused on fibrillar collagens as collagen I, III or on collagens associated to basement 
membranes (collagen IV). Cellular origin and distribution of FACIT collagens and their 
contribution to matrix alterations in intestinal inflammatory processes have not been 
addressed yet. The functional and structural diversity of extracellular matrices is 
determined by individual macromolecules and the aggregates they form. Although, 
quantitatively major matrix molecules as fibrillar collagens can occur ubiquitously, their 
organization varies tissue specifically due to their association with specific sets of minor 
components, i.e. FACIT-collagens. They are part of the fibrillar periphery constituting 
the interface between extrafibrillar matrix and the fibrillar body. These collagens can 
attach adapter molecules as matrilins and COMP capable of interconnecting 
macromolecular networks and thus mediating interactions between fibrillar aggregates 
and the extrafibrillar matrix including cells (Budde et al., 2005; Kassner et al., 2003). 
Therefore, an intact peripheral composition of fibrils is a prerequisite for the integrity 
and stability of the whole ECM. Presence and distribution of FACIT-collagens in skin, 
cornea and cartilage have been well documented, however, information about 
localization, metabolism, and cellular source of FACIT-collagens in the bowel wall is 
unavailable. Our histological studies demonstrated deposition of collagen XVI in the 
normal, non-inflamed and inflamed, due to fibrosis expanded, submucosa and lamina 
propria of the strictured bowel. Both, epithelial cells and subepithelial myofibroblasts 
which are localized subjacent to the basement membrane and in close vicinity of the 
basal surface of the epithelial cell layer express collagen XVI with a prominent 
deposition of collagen XVI into the matrix of the epithelial crypts. This particular 
distribution is inverse to the dermal situation where collagen XVI is localized in defined 
zones adjacent to basement membranes preferentially on the dermal side of the dermo-
epidermal junction (DEJ) even though expressed by keratinocytes (Grassel et al., 1999).  
We suggest collagen XVI to contribute to stabilization and maintenance of basement 
membranes in the normal bowel wall as it was proposed for the DEJ in skin. It is 
predominantly expessed by intestinal myofibroblasts of the lamina propria and 
epithelial cells of the crypts. Increased gene and protein expression in ISEMF isolated 
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from inflamed CD tissue biopsies indicates a distinct role of collagen XVI during 
progression and/or maintenance of inflammation.  
 
6.2.2. Role of collagen XVI in adhesion, migration, and proliferation potential 
of ISEMF 
 
Adhesion properties influenced by collagen XVI 
The first phase in integrin-mediated signal transduction is the formation of focal 
adhesion contacts. Our study on the integrin expression pattern of differently inflamed 
ISEMF revealed increasing α1 integrin expression concomitant to elevated collagen 
XVI gene and protein expression. Four collagen-binding I domain-containing integrins 
are currently known: α1β1, α2β1, α10β1 and α11β1 (Gullberg and Lundgren-Akerlund, 
2002). For the integrins α1 and α2 an interaction with collagen XVI has been 
determined and a binding site for α1 integrin was identified in the C-terminal domain of 
collagen XVI (Eble et al., 2006). α1β1 is proposed as sole integrin utilized by 
contracting myofibroblasts in vivo. Although α2β1 is capable of mediating contraction, 
its expression by myofibroblasts is supposed to occur largely, if not exclusively, in 
response to cell culture (Racine-Samson et al., 1997). α2ß1 integrin has been shown to 
be dispensable for fibroblast adhesion (Zhang et al., 2006). Collagen-binding integrins 
are co-expressed by fibroblasts, however, they may not act simultaneously. α2ß1 
integrin is important in the very early steps of fibroblast adhesion to collagen I. In later 
stages of adhesion other receptors can completely or partially compensate for the lack of 
α2ß1 integrin (Zhang et al., 2006). α1ß1 integrin is responsible for fibroblast adhesion 
to collagen I, collagen IV and laminin, as well as to collagen XVI (Eble et al., 2006; 
Zhang et al., 2006). Cell-free protein binding assays revealed a stronger interaction of 
α1ß1 integrin with collagen XVI than α2ß1 integrin. Dependent on the cell type, 
adhesion is facilitated by several integrins. A rat glioma cell line (RuGli) adhered via 
α1ß1 integrin to collagen XVI (Eble et al., 2006), whereas human fibrosarcoma cells 
showed mainly interaction via predominantly expressed α2ß1 to collagens in general 
(Perret et al., 2003; Vandenberg et al., 1991).  
Integrin-collagen binding results in mechanical anchorage of cells and signals are 
transmitted from the ECM via integrins into the cells. The formation of focal adhesion 
contacts is the primary step in integrin-mediated signal transduction. Our 
immunofluorescence studies on α1 integrin showed a recruitment of this integrin into 
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the supramolecular structures of focal adhesion contacts. To visualize focal adhesion 
contacts, we used vinculin, a protein present in focal adhesion plaques. Focal adhesion 
contacts of ISEMF on collagen XVI contained α1 integrin and vinculin and were 
increased in number and length. Inflamed ISEMF revealed generally increased α1 
integrin levels and also a recruitment of this integrin into focal adhesion contacts all 
over the cellular body when seeded on collagen XVI. Cells spread on collagen XVI 
similar to collagen I, however, have longer streak-like focal adhesion contacts. Together 
with increased collagen XVI gene and protein expression in ISEMF from inflamed 
tissue it suggests that collagen XVI is a physiological substrate for myofibroblasts in 
vivo and may act as agonist inducing an integrin-mediated signal transduction resulting 
in increased cell spreading and alterations in cell morphology. ISEMF that have been 
adhered on collagen XVI developed an extensive cell spreading compared to collagen I 
where cells remained more roundish. Analysis of development and maturation of focal 
adhesion contacts formed by ISEMF revealed elevated formation on collagen XVI as 
culture substrate compared to collagen I and poly-L-lysine. The maturation of focal 
adhesion contacts was also augmented by collagen XVI. After 24 hrs ISEMF revealed 
longer focal adhesion contacts when seeded on collagen XVI compared to poly-L-
lysine, however, not significantly different from those formed on collagen I. 
Nevertheless, our adhesion assays revealed no significant changes in adhesion capacity 
of ISEMF with respect to increasing inflammation on collagen XVI, whereas ISEMF 
from non-inflamed tissue biopsies adhere less to collagen XVI compared to collagen I. 
This might be due to a differential integrin surface expression profile or clustering of 
ISEMF in inflamed regions of the intestinal wall. We demontstrated that ISEMF from 
normal colon tissue biopsies express less α1 integrin as do cells from inflamed areas. 
This integrin has a high affinity recognition site in the C-terminal region of collagen 
XVI and binds with profound higher affinity to collagen XVI as does the α2 integrin 
subunit (Eble et al., 2006).  
Fibrotic tissue reveals extensive cell-matrix contacts that are absent from normal 
connective tissue (Eyden, 2005). Our data implicate that collagen XVI is a preferred 
substrate for the formation of focal adhesion contacts and therefore promotes more 
stable and prolonged adhesion of ISEMF to the underlying matrix. This observation is 
supported by the distribution pattern of focal adhesion contacts. On collagen XVI as 
substrate focal adhesion contacts are also found in the centre of the cell, whereas on 
poly-L-lysine focal adhesion points are mainly restricted to the cellular periphery. 
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Collagen XVI seems to provide more stiffness resulting in higher tension that 
immobilizes cells. Recently, we have shown that collagen XVI promotes adhesion of 
glioblastoma cell lines thus presumably playing a role in regulation of adhesive 
properties of tumor cells (Senner et al., 2008). Possibly, increased accumulation of 
collagen XVI in inflamed colon tissue would help to promote a pathological 
continuance of ISEMF by keeping the cells at the inflammation site. It is conceivable 
that collagen XVI is a preferred substrate for formation of focal adhesion contacts and 
thereafter extensive cell spreading since it might be easier to contact by the cells due to 
its exposed peripheral location on fibrillar structures compared to collagen I which 
forms the body of fibrils. 
 
Migration and proliferation properties influenced by collagen XVI 
In normal tissue repair fibroblasts migrate into the open wound where they synthesize 
and remodel the ECM to close the wound. Fibrosis occurs by the failure to terminate the 
physiological tissue remodelling program. The crucial point in tissue repair is the ability 
of fibroblasts to attach to ECM followed by cell migration and ECM contraction (Hinz 
and Gabbiani, 2003). Adhesion to ECM is facilitated by integrins who transmit 
extracellular signals through focal adhesion kinase (FAK). FAK is present in focal 
adhesions and is phosphorylated after intergrin-mediated cell attachment (Parsons, 
2003). Fibrotic cells are characterized by activated adhesion and adhesive signalling 
(Chen et al., 2005; Desmouliere et al., 2005; Mimura et al., 2005). Adhesion is not only 
a process engaging attachment of fibroblasts to ECM, however, also results in 
downstream expression of genes involved in tissue remodelling and repair. Therefore, 
fibroblast attachment is actively interacting with a promotion in tissue repair processes 
and may induce the expression and secretion of components of the ECM (Kennedy et 
al., 2008). During culture of fibroblasts ECM is synthesized and deposited. Differences 
in ECM production of fibrotic or non-fibrotic cells may significantly alter ECM 
composition and pro-fibrotic gene expression in a feed-back loop (Shi-Wen et al., 
2007). Attachment to the ECM regulates proliferation and migration of cells (Schwartz 
and Assoian, 2001), however collagen XVI as substrate did neither alter proliferation 
nor migration rates of ISEMF. Collagen XVI rather seems to immobilize initially 
adhered ISEMF to the normal colon wall and to a higher extent at the inflammation site 
in late stages of the inflammation process than to influence proliferation or migration 
properties. Focal adhesion contacts are found all over the cell which is characteristic for 
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highly motile focal adhesion contacts in stationary cells (Smilenov et al., 1999). 
Although, we have not found a proliferation or migration promoting effect of pure 
collagen XVI in our monolayer migration assays, collagen XVI may act as migration 
promoting substance in combination with other factors e.g. in allocation of three 
dimensional structures through interconnection to other structural proteins in a mucosal 
specific ECM. The proliferation experiments refer to total cell number, indirectly 
determined by enzyme activity. As we could exclude any effect of culture substrates on 
cell viability, we assume a direct relation of total cell number to proliferation. 
Different collagens co-assemble into heterotypic fibrils. The relative composition and 
the amounts of these collagens define the structure and organization of the extracellular 
matrix network and determine biomechanical properties of these tissues. Members of 
the FACIT collagens are multi-domain molecules that are associated with collagen 
fibrils to form more complex alloys. The regulated expression of these peripheral 
molecules represents the molecular basis of the structural diversity of connective tissue. 
FACIT collagens serve as molecular bridges that are important for the organization and 
stability of extracellular matrices. Therefore, abnormalities in the expression of FACIT 
collagens may also contribute to pathological changes in several connective tissues 
(Akagi et al., 1999; Senner et al., 2008).  
 
Summary and conclusion  
Recombinant expression of collagen XVI was reproducible and allowed a variety of 
experimental set-ups with respect to investigations of pathological disorders and 
functional studies on collagen XVI. 
Supramolecular structures which exhibit a variety of compositions of their components 
support mechanical properties of specialized tissues. The deposition of collagen XVI 
into the lamina propria and submucosa by myofibroblasts and epithelial cells of the 
human bowel wall is inverse to the dermal distribution. Collagen XVI is associated to 
fibrillin-1 containing microfibrils in the human skin and to D-periodically banded 
cartilage fibrils, whereas in the human colon a specific binding partner is still unknown. 
Collagen XVI presumably acts as adapter molecule by interconnecting marcromolecular 
structures. The distribution pattern of collagen XVI in the submucosa and lamina 
propria may support the motility of fibrous tissue compartments in the human bowel 
wall. However, with increasing inflammation and beginning fibrosis the homeostasis 
and peristaltic movement of the bowel is disturbed. In these pathological situations 
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observed in CD, collagen XVI gene and protein expression is up-regulated. The 
intestinal myofibroblast is the key player in chronic bowel wall inflammation processes. 
These cells mediate stricture formation and are responsible for excessive collagen 
matrix production and deposition. Collagen XVI is produced by ISEMF in the normal 
intestine and its synthesis is increased in the inflamed bowel wall. Collagen XVI 
promotes cell spreading and formation of focal adhesion contacts, but has no influence 
on proliferation and migration of ISEMF in our experimental set up. ISEMF develop 
increased numbers of focal adhesion contacts concomitant with α1 integrin expression. 
Focal adhesion contacts also displayed an increase in length on collagen XVI and that 
way promoting extensive spreading of the cells. This behaviour presumably adds to the 
maintenance of cells in the inflamed intestinal regions and thus promotes fibrotic 
responses of the tissue and prolongs further disturbances of the delicate homeostasis 
between cells and surrounding ECM. We suggest that collagen XVI can alter force 
transmission and ECM remodelling by changing the mechanical properties of the ECM. 
 
Part II: Establishment of a retroviral mediated gene silencing model 
 
6.3. Gene silencing of collagen XVI in murine NIH3T3 fibroblasts 
6.3.1. Downstream gene and protein expression 
2D-gelelectrophoresis of knockdown NIH3T3 cell lysates showed differentially 
expressed proteins due to the collagen XVI knockdown compared to the control. The 
housekeeping protein ß-actin remained unaffected indicating collagen XVI gene 
silencing to be specific and not because of RNAi induced unspecific silencing or viral 
interferon mediated off-target mechanism. Differentially expressed proteins in collagen 
XVI silenced cells were identified as macrophage migration inhibitory factor (MIF) and 
prolyl-peptidyl-cis-trans-isomerase A (PPIA). PPIA is is an abundant, ubiquitously 
expressed protein that influences the conformation of proteins in cells (Colgan et al., 
2000).  It catalyzes cis-trans-interconversions of peptides and is involved in general 
physiological processes like the maintenance of protein structure (Schiene and Fischer, 
2000). PPIA is commonly used in gene expression analysis as housekeeping gene 
appearing less regulated than GAPDH (Feroze-Merzoug et al., 2002). However, in 
murine NIH3T3 fibroblasts silenced for collagen XVI its expression was dramatically 
decreased. MIF is a proinflammatory autocrine mediator which influences proliferative 
and oncogenic processes (Liao et al., 2003). As a central regulator of innate immunity 
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and inflammation it is associated with tissue injury (Hardman et al., 2005) and was 
down-regulated in collagen XVI silenced NIH3T3 fibroblasts. 
 
6.3.2. Functional consequences of collagen XVI knockdown 
Proliferation and adhesion assays were performed for knockdown NIH3T3 fibroblasts 
and controls and revealed a reduced adhesion and proliferation capacity of cells lacking 
collagen XVI. However, adhesive and proliferative potential were not affected by 
collagen I or collagen XVI serving as culture substrates.  
Collagen XVI silenced fibroblasts show a generally reduced proliferation capacity 
which is not related to the external ECM-stimulus in parallel to a decrease in MIF 
protein expression. MIF is known to be secreted in a PKC-dependent way as a 
consequence of cell adhesion to the extracellular matrix and plays a role in integrin-
mediated signalling to sustained MAP kinase, cyclin D1 expression, and cell cycle 
progression (Liao et al., 2003). MIF was initially described as soluble factor in a culture 
medium of activated T-cells (Bloom and Bennett, 1966); however, without elucidating 
the accurate biological function. The anterior pituitary gland relases MIF as a hormone 
in endotoxin shock (Bernhagen et al., 1993; Nishino et al., 1995). It is also produced as 
a proinflammatory cytokine and glucocorticoid-induced immonomodulator by 
macrophages in response to a variety of inflammatory stimuli (Calandra et al., 1994). In 
synovial fibroblasts of rheumatoid arthritis patients MIF up-regulates IL-8 gene 
expression. This indicates a role in the migration of inflammatory cells into the 
synovium of rheumatoid joints via the IL-8 induction (Onodera et al., 2004). MIF is a 
critical regulator of cell functions such as gene expression, proliferation or apoptosis. It 
is reported that MIF activates the ERK pathway involving phosphorylation and 
activation of Raf-1, MEK, ERK-1/2 and Elk-1 (Swant et al., 2005). A study on MIF 
knockout mice revealed an accelerating effect of MIF in cutanous wound healing (Zhao 
et al., 2005). We suggest a secondary effect of the collagen XVI knockdown on cellular 
proliferation mediated by a reduction of MIF protein expression. In contrast to protein 
expression gene expression of MIF was not down-regulated by collagen XVI silencing. 
In prostate cancer cells MIF showed increased levels of gene expression and a higher 
mRNA stability compared to prostate epithelial cells (Meyer-Siegler, 2000). We assume 
a delayed effect on MIF gene expression due to longer mRNA half-life and therefore a 
discrepancy between gene and protein expression. The lack of collagen XVI resulting in 
a reduction of MIF protein expression may therefore act in a negative feedback loop on 
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cellular proliferation. After 90 min of adhesion the rates of knockdown cells remained 
below those of the luciferase vector control. However, reduced proliferation capacity is 
not a consequence of a lower number of adhered cells as demonstrated for 18 hrs of 
adhesion. The knockdown of collagen XVI may influence cellular mechanisms like 
proliferation. However, the type of culture substrate did not influence this behaviour 
significantly.  
Like MIF, the prolylpeptidyl-cis-trans isomerise A (PPIA) was down-regulated in 
collagen XVI knockdown fibroblasts. PPIA catalyzes cis/trans isomerization of the 
peptide bond preceding the proline in a polypeptide chain. This process is important in 
de novo protein folding and in isomerization of native proteins (Endlich et al., 2006). 
Changes in isomerase activity can alter the transactivation potential, protein stability or 
intra-cellular localization of proteins. Disturbed cell proliferation and tumorigenesis are 
linked with these processes (Shaw, 2007). However, a direct relation of PPIA with 
collagen XVI has to be further elucidated.  
 
Summary and conclusion 
Retroviral mediated gene silencing together with 2-D-gelelectrophoresis provides potent 
tools for downstream gene-function analysis. The knockdown of collagen XVI 
established in NIH3T3 cells can be transferred to any dividing cell type. Therefore, a 
large variety of functional testing is possible. For the NIH3T3 cells the specific collagen 
XVI silencing results in a generally reduced proliferation and adhesion capcity 
accompanied by down-regulation of MIF and PPIA protein expression. The reduction of 
PPIA could influence correct protein folding, however, remains to be further 
investigated. The decrease in MIF may indicate an indirect effect of collagen XVI 
knockdown on cellular proliferation. Initial adhesion of collagen XVI silenced cells is 
disturbed and irrespective of the coating substrate.  
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7. Affixes 
7.1 Bacterial cloning vectors 
 
Figure 7-1: Cloning vector pCR®4-TOPO (ampicillin and kanamycin resistance, 
Invitrogen, UK) 
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EBNA-1
EcoRI 4694
Amp
Puromycin resistence
Pac/PSV40pCEP Pu + BM40 SP
9608 bp
OriP
EcoRV 8999
BamHI 406
XhoI 424
Hind III 540
Kpn I 564
Not I 429 Nhe I 435
SV40pA
BM40SP
pCMV
SV40pA
 
Figure 7-2: Expression vector pCEP PU BM40SP 
Not I and Nhe I within the MCS are framed. The black area refers to the coding 
sequence of the BM40 signal peptide (BM40SP). The vector contains an ampicillin 
resistance for selection in prokaryotes and a puromycin resistance for selection in 
mammalian cells.  
This vector is based on a no longer commercially available expression vector pCEP Pu 
from Invitrogen, UK. The vector has been modified by insertion of a BM40 signal 
peptide and several tag sequences (Kohfeldt et al., 1996; Kohfeldt et al., 1997; Smyth et 
al., 2000) and recombinant expression of collagen XVI with this vector has been 
established previously (Kassner et al., 2004). 
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Figure 7-3: RNAi-Ready pSIREN-RetroQ vector. A self-inactivating retroviral 
expression vector designed to express a small interfering double stranded RNA 
(shRNA) using the human U6 promoter. 
7.2 Antibodies 
 
antibody species antigen, source final dilution  
gp-anti-Col 
XVI 
Guinea pig, 
polyclonal antiserum, 
protein A purified 
Full length recombinant 
collagen XVI 
IB: 1:1000 
IF (colon 
sections): 1:10 
+TSA enhancer 
kit 
IF (cells): 1:75 
Strep II Mouse, monoclonal StrepII-Tag (GenScript, 
USA) 
IB: 0.1 µg/ml 
AGF1 Mouse, monoclonal α1-integrin (kind gift 
from Johannes A. Eble) 
FC: 6.3 µg/µl 
MAB1973Z Mouse, monoclonal α1-integrin (Millipore, IF:1:150 
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Germany) 
JA221 Mouse, monoclonal α2-integrin (kind gift 
from Johannes A. Eble) 
FC: 2.6 µg/µl 
CD49bAK-7 Mouse, monoclonal α2-integrin (Bio-Legend, 
USA) 
FC: 1:25 
mAB13 Rat, polyclonal β1-integrin (kind gift 
from Johannes A. Eble) 
FC: 1:1000 
alpha 10 Mouse, monoclonal α10-integrin (kind gift of 
Evi Lundgren-Ackerlund) 
FC: 0.57 µg/µl 
alpha 11 Rabbit, polyclonal α11-integrin (kind gift of 
Evi Lundgren-Ackerlund) 
FC: 1:500 
ms-anti-Vinc Mouse, monoclonal Human vinculin (Sigma-
Aldrich, USA) 
IF: 1:500 
rbt-anti-Vinc Rabbit, polyclonal Human vinculin (Sigma-
Aldrich, USA) 
IF: 1:400 
rbt-anti-
PPIA 
Rabbit, polyclonal Human peptidyl-prolyl-
cis-trans isomerise A 
(Acris, USA) 
IB: 1:500 
rbt-anti-MIF Rabbit, polyclonal Human macrophage 
migration inhibitory 
factor (Santa Cruz, USA) 
IB: 1:200 
ms-anti-
SMA 
Mouse, monoclonal Human smooth muscle 
actin clone 1A4 (DAKO, 
Denmark) 
IF:1:25 
ms-anti-FN Mouse, monoclonal Human fibronectin IgG1 
(Acris, USA) 
IF:1:20 
 
Table 7-1: List of primary antibodies. gp: guinea pig; rbt: rabbit; ms: mouse;  IB = 
Immunoblot; IF = Immunofluorescence; FC = flow cytometry 
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antibody final dilution 
Goat-anti-gp Alexa Fluor® 555, Molecular Probes, USA 5 µg/ml 
Goat-anti-ms Alexa Fluor® 488, Molecular Probes, USA 5 µg/ml 
Goat-anti-ms Alexa Fluor® 568, Molecular Probes, USA 5 µg/ml 
Goat-anti-gp biotinylated antibody, Sigma-Aldrich, USA 1:800 
Phalloidin-Alexa Fluor® 568, Sigma-Aldrich, USA 1:40 
DAPI Nucleic Acid Stain, Molecular Probes, USA 300 nM 
 
Table 7-2: List of secondary antibodies used for immunofluorescence. 
gp: guinea pig; rbt: rabbit; ms: mouse 
 
antibody final dilution 
Goat-anti-gp peroxidase conjugated (Sigma-Aldrich, 
USA) 
1:30,000 
 
Goat-anti-ms peroxidase conjugated (Pierce, USA) 1:30,000 
Goat-anti-rbt peroxidase conjugated (Pierce, USA) 1:30,000 
 
Table 7-3: List of secondary antibodies used for immunoblotting. 
gp: guinea pig; rbt: rabbit; ms: mouse 
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